Financial Metrics

MRK Merck & Co., Inc.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 26 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-06-30	9930000000.0	—	USD	10-Q	2018-08-07
Quarterly	2017-09-30	10325000000.0	+4.0%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	10037000000.0	-2.8%	USD	10-Q	2019-05-08
Quarterly	2018-06-30	10465000000.0	+4.3%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	10794000000.0	+3.1%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	10816000000.0	+0.2%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	11760000000.0	+8.7%	USD	10-Q	2020-08-05
Quarterly	2019-09-30	12397000000.0	+5.4%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	12057000000.0	-2.7%	USD	10-Q	2021-05-05
Quarterly	2020-06-30	9353000000.0	-22.4%	USD	10-Q	2021-08-09
Quarterly	2020-09-30	10929000000.0	+16.9%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	10627000000.0	-2.8%	USD	10-Q	2022-05-05
Quarterly	2021-06-30	11402000000.0	+7.3%	USD	10-Q	2022-08-05
Quarterly	2021-09-30	13154000000.0	+15.4%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	15901000000.0	+20.9%	USD	10-Q	2023-05-05
Quarterly	2022-06-30	14593000000.0	-8.2%	USD	10-Q	2023-08-07
Quarterly	2022-09-30	14959000000.0	+2.5%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	14487000000.0	-3.2%	USD	10-Q	2024-05-03
Quarterly	2023-06-30	15035000000.0	+3.8%	USD	10-Q	2024-08-05
Quarterly	2023-09-30	15962000000.0	+6.2%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	15775000000.0	-1.2%	USD	10-Q	2025-05-02
Quarterly	2024-06-30	16112000000.0	+2.1%	USD	10-Q	2025-08-05
Quarterly	2024-09-30	16657000000.0	+3.4%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	15529000000.0	-6.8%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	15806000000.0	+1.8%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	17276000000.0	+9.3%	USD	10-Q	2025-11-05
Annual	2016-12-31	39807000000.0	—	USD	10-K	2019-02-27
Annual	2017-12-31	40122000000.0	+0.8%	USD	10-K	2020-02-26
Annual	2018-12-31	42294000000.0	+5.4%	USD	10-K	2021-02-25
Annual	2019-12-31	39121000000.0	-7.5%	USD	10-K	2022-02-25
Annual	2020-12-31	41518000000.0	+6.1%	USD	10-K	2023-02-24
Annual	2021-12-31	48704000000.0	+17.3%	USD	10-K	2024-02-26
Annual	2022-12-31	59283000000.0	+21.7%	USD	10-K	2025-02-25
Annual	2023-12-31	60115000000.0	+1.4%	USD	10-K	2026-02-24
Annual	2024-12-31	64168000000.0	+6.7%	USD	10-K	2026-02-24
Annual	2025-12-31	65011000000.0	+1.3%	USD	10-K	2026-02-24

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Operating Income

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1130000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	1209000000.0	+7.0%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	2188000000.0	+81.0%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	1556000000.0	-28.9%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	1951000000.0	+25.4%	USD	10-Q	2018-08-07
Quarterly	2017-09-30	-51000000.0	-102.6%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	741000000.0	+1552.9%	USD	10-Q	2019-05-08
Quarterly	2018-06-30	1716000000.0	+131.6%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	1958000000.0	+14.1%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	2862000000.0	+46.2%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	2644000000.0	-7.6%	USD	10-Q	2020-08-05
Quarterly	2019-09-30	1907000000.0	-27.9%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	3219000000.0	+68.8%	USD	10-Q	2021-05-05
Quarterly	2020-06-30	3002000000.0	-6.7%	USD	10-Q	2021-08-09
Quarterly	2020-09-30	2941000000.0	-2.0%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	3179000000.0	+8.1%	USD	10-Q	2022-05-05
Quarterly	2021-06-30	1545000000.0	-51.4%	USD	10-Q	2022-08-05
Quarterly	2021-09-30	4567000000.0	+195.6%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	4307000000.0	-5.7%	USD	10-Q	2023-05-05
Quarterly	2022-06-30	3949000000.0	-8.3%	USD	10-Q	2023-08-07
Quarterly	2022-09-30	3253000000.0	-17.6%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	2825000000.0	-13.2%	USD	10-Q	2024-05-03
Quarterly	2023-06-30	-5972000000.0	-311.4%	USD	10-Q	2024-08-05
Quarterly	2023-09-30	4750000000.0	+179.5%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	4767000000.0	+0.4%	USD	10-Q	2025-05-02
Quarterly	2024-06-30	5461000000.0	+14.6%	USD	10-Q	2025-08-05
Quarterly	2024-09-30	3161000000.0	-42.1%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	5085000000.0	+60.9%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	4428000000.0	-12.9%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	5787000000.0	+30.7%	USD	10-Q	2025-11-05
Annual	2016-12-31	3941000000.0	—	USD	10-K	2019-02-27
Annual	2017-12-31	2418000000.0	-38.6%	USD	10-K	2020-02-26
Annual	2018-12-31	6193000000.0	+156.1%	USD	10-K	2021-02-25
Annual	2019-12-31	9843000000.0	+58.9%	USD	10-K	2022-02-25
Annual	2020-12-31	7067000000.0	-28.2%	USD	10-K	2023-02-24
Annual	2021-12-31	13049000000.0	+84.6%	USD	10-K	2024-02-26
Annual	2022-12-31	14526000000.0	+11.3%	USD	10-K	2025-02-25
Annual	2023-12-31	377000000.0	-97.4%	USD	10-K	2026-02-24
Annual	2024-12-31	17133000000.0	+4444.6%	USD	10-K	2026-02-24
Annual	2025-12-31	18263000000.0	+6.6%	USD	10-K	2026-02-24

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.41	—	USD/shares	10-Q	2017-05-09
Quarterly	2016-06-30	0.44	+7.3%	USD/shares	10-Q	2017-08-08
Quarterly	2016-09-30	0.79	+79.5%	USD/shares	10-Q	2017-11-07
Quarterly	2017-03-31	0.56	-29.1%	USD/shares	10-Q	2018-05-08
Quarterly	2017-06-30	0.71	+26.8%	USD/shares	10-Q	2018-08-07
Quarterly	2017-09-30	-0.02	-102.8%	USD/shares	10-Q	2018-11-06
Quarterly	2018-03-31	0.27	+1450.0%	USD/shares	10-Q	2019-05-08
Quarterly	2018-06-30	0.64	+137.0%	USD/shares	10-Q	2019-08-06
Quarterly	2018-09-30	0.73	+14.1%	USD/shares	10-Q	2019-11-05
Quarterly	2019-03-31	1.13	+54.8%	USD/shares	10-Q	2020-05-06
Quarterly	2019-06-30	1.04	-8.0%	USD/shares	10-Q	2020-08-05
Quarterly	2019-09-30	0.74	-28.8%	USD/shares	10-Q	2020-11-05
Quarterly	2020-03-31	1.27	+71.6%	USD/shares	10-Q	2021-05-05
Quarterly	2020-06-30	1.19	-6.3%	USD/shares	10-Q	2021-08-09
Quarterly	2020-09-30	1.16	-2.5%	USD/shares	10-Q	2021-11-05
Quarterly	2021-03-31	1.26	+8.6%	USD/shares	10-Q	2022-05-05
Quarterly	2021-06-30	0.61	-51.6%	USD/shares	10-Q	2022-08-05
Quarterly	2021-09-30	1.81	+196.7%	USD/shares	10-Q	2022-11-03
Quarterly	2022-03-31	1.7	-6.1%	USD/shares	10-Q	2023-05-05
Quarterly	2022-06-30	1.56	-8.2%	USD/shares	10-Q	2023-08-07
Quarterly	2022-09-30	1.28	-17.9%	USD/shares	10-Q	2023-11-03
Quarterly	2023-03-31	1.11	-13.3%	USD/shares	10-Q	2024-05-03
Quarterly	2023-06-30	-2.35	-311.7%	USD/shares	10-Q	2024-08-05
Quarterly	2023-09-30	1.87	+179.6%	USD/shares	10-Q	2024-11-06
Quarterly	2024-03-31	1.88	+0.5%	USD/shares	10-Q	2025-05-02
Quarterly	2024-06-30	2.15	+14.4%	USD/shares	10-Q	2025-08-05
Quarterly	2024-09-30	1.25	-41.9%	USD/shares	10-Q	2025-11-05
Quarterly	2025-03-31	2.01	+60.8%	USD/shares	10-Q	2025-05-02
Quarterly	2025-06-30	1.76	-12.4%	USD/shares	10-Q	2025-08-05
Quarterly	2025-09-30	2.32	+31.8%	USD/shares	10-Q	2025-11-05
Annual	2016-12-31	1.42	—	USD/shares	10-K	2019-02-27
Annual	2017-12-31	0.88	-38.0%	USD/shares	10-K	2020-02-26
Annual	2018-12-31	2.34	+165.9%	USD/shares	10-K	2021-02-25
Annual	2019-12-31	3.84	+64.1%	USD/shares	10-K	2022-02-25
Annual	2020-12-31	2.79	-27.3%	USD/shares	10-K	2023-02-24
Annual	2021-12-31	5.16	+84.9%	USD/shares	10-K	2024-02-26
Annual	2022-12-31	5.73	+11.0%	USD/shares	10-K	2025-02-25
Annual	2023-12-31	0.14	-97.6%	USD/shares	10-K	2026-02-24
Annual	2024-12-31	6.76	+4728.6%	USD/shares	10-K	2026-02-24
Annual	2025-12-31	7.3	+8.0%	USD/shares	10-K	2026-02-24

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.4	—	USD/shares	10-Q	2017-05-09
Quarterly	2016-06-30	0.43	+7.5%	USD/shares	10-Q	2017-08-08
Quarterly	2016-09-30	0.78	+81.4%	USD/shares	10-Q	2017-11-07
Quarterly	2017-03-31	0.56	-28.2%	USD/shares	10-Q	2018-05-08
Quarterly	2017-06-30	0.71	+26.8%	USD/shares	10-Q	2018-08-07
Quarterly	2017-09-30	-0.02	-102.8%	USD/shares	10-Q	2018-11-06
Quarterly	2018-03-31	0.27	+1450.0%	USD/shares	10-Q	2019-05-08
Quarterly	2018-06-30	0.63	+133.3%	USD/shares	10-Q	2019-08-06
Quarterly	2018-09-30	0.73	+15.9%	USD/shares	10-Q	2019-11-05
Quarterly	2019-03-31	1.12	+53.4%	USD/shares	10-Q	2020-05-06
Quarterly	2019-06-30	1.03	-8.0%	USD/shares	10-Q	2020-08-05
Quarterly	2019-09-30	0.74	-28.2%	USD/shares	10-Q	2020-11-05
Quarterly	2020-03-31	1.26	+70.3%	USD/shares	10-Q	2021-05-05
Quarterly	2020-06-30	1.18	-6.3%	USD/shares	10-Q	2021-08-09
Quarterly	2020-09-30	1.16	-1.7%	USD/shares	10-Q	2021-11-05
Quarterly	2021-03-31	1.25	+7.8%	USD/shares	10-Q	2022-05-05
Quarterly	2021-06-30	0.61	-51.2%	USD/shares	10-Q	2022-08-05
Quarterly	2021-09-30	1.8	+195.1%	USD/shares	10-Q	2022-11-03
Quarterly	2022-03-31	1.7	-5.6%	USD/shares	10-Q	2023-05-05
Quarterly	2022-06-30	1.55	-8.8%	USD/shares	10-Q	2023-08-07
Quarterly	2022-09-30	1.28	-17.4%	USD/shares	10-Q	2023-11-03
Quarterly	2023-03-31	1.11	-13.3%	USD/shares	10-Q	2024-05-03
Quarterly	2023-06-30	-2.35	-311.7%	USD/shares	10-Q	2024-08-05
Quarterly	2023-09-30	1.86	+179.1%	USD/shares	10-Q	2024-11-06
Quarterly	2024-03-31	1.87	+0.5%	USD/shares	10-Q	2025-05-02
Quarterly	2024-06-30	2.14	+14.4%	USD/shares	10-Q	2025-08-05
Quarterly	2024-09-30	1.24	-42.1%	USD/shares	10-Q	2025-11-05
Quarterly	2025-03-31	2.01	+62.1%	USD/shares	10-Q	2025-05-02
Quarterly	2025-06-30	1.76	-12.4%	USD/shares	10-Q	2025-08-05
Quarterly	2025-09-30	2.32	+31.8%	USD/shares	10-Q	2025-11-05
Annual	2016-12-31	1.41	—	USD/shares	10-K	2019-02-27
Annual	2017-12-31	0.87	-38.3%	USD/shares	10-K	2020-02-26
Annual	2018-12-31	2.32	+166.7%	USD/shares	10-K	2021-02-25
Annual	2019-12-31	3.81	+64.2%	USD/shares	10-K	2022-02-25
Annual	2020-12-31	2.78	-27.0%	USD/shares	10-K	2023-02-24
Annual	2021-12-31	5.14	+84.9%	USD/shares	10-K	2024-02-26
Annual	2022-12-31	5.71	+11.1%	USD/shares	10-K	2025-02-25
Annual	2023-12-31	0.14	-97.5%	USD/shares	10-K	2026-02-24
Annual	2024-12-31	6.74	+4714.3%	USD/shares	10-K	2026-02-24
Annual	2025-12-31	7.28	+8.0%	USD/shares	10-K	2026-02-24

Balance Sheet

Metrics: 9

Cash and Equivalents

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	9716000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	6608000000.0	-32.0%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	7907000000.0	+19.7%	USD	10-Q	2017-11-07
Quarterly	2016-12-31	6515000000.0	-17.6%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	11708000000.0	+79.7%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	7786000000.0	-33.5%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	7901000000.0	+1.5%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	6092000000.0	-22.9%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	4483000000.0	-26.4%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	5310000000.0	+18.4%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	7826000000.0	+47.4%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	7965000000.0	+1.8%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	8076000000.0	+1.4%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	6659000000.0	-17.5%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	7869000000.0	+18.2%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	9676000000.0	+23.0%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	7425000000.0	-23.3%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	11103000000.0	+49.5%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	7356000000.0	-33.7%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	8050000000.0	+9.4%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	6981000000.0	-13.3%	USD	10-Q	2021-05-05
Quarterly	2021-06-30	8575000000.0	+22.8%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	10016000000.0	+16.8%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	8096000000.0	-19.2%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	8556000000.0	+5.7%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	9675000000.0	+13.1%	USD	10-Q	2022-08-05
Quarterly	2022-09-30	11145000000.0	+15.2%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	12694000000.0	+13.9%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	9707000000.0	-23.5%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	5660000000.0	-41.7%	USD	10-Q	2023-08-07
Quarterly	2023-09-30	8605000000.0	+52.0%	USD	10-Q	2023-11-03
Quarterly	2023-12-31	6841000000.0	-20.5%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	5579000000.0	-18.4%	USD	10-Q	2024-05-03
Quarterly	2024-06-30	11304000000.0	+102.6%	USD	10-Q	2024-08-05
Quarterly	2024-09-30	14593000000.0	+29.1%	USD	10-Q	2024-11-06
Quarterly	2024-12-31	13242000000.0	-9.3%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	8629000000.0	-34.8%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	8007000000.0	-7.2%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	18169000000.0	+126.9%	USD	10-Q	2025-11-05
Annual	2016-12-31	6515000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	6092000000.0	-6.5%	USD	10-K	2019-02-27
Annual	2018-12-31	7965000000.0	+30.7%	USD	10-K	2020-02-26
Annual	2019-12-31	9676000000.0	+21.5%	USD	10-K	2021-02-25
Annual	2020-12-31	8050000000.0	-16.8%	USD	10-K	2022-02-25
Annual	2021-12-31	8096000000.0	+0.6%	USD	10-K	2023-02-24
Annual	2022-12-31	12694000000.0	+56.8%	USD	10-K	2024-02-26
Annual	2023-12-31	6841000000.0	-46.1%	USD	10-K	2025-02-25
Annual	2024-12-31	13242000000.0	+93.6%	USD	10-K	2026-02-24
Annual	2025-12-31	14565000000.0	+10.0%	USD	10-K	2026-02-24

Accounts Receivable

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	6850000000.0	—	USD	10-Q	2016-05-09
Quarterly	2016-06-30	6916000000.0	+1.0%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	7364000000.0	+6.5%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	7018000000.0	-4.7%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	7066000000.0	+0.7%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	7439000000.0	+5.3%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	7671000000.0	+3.1%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	6873000000.0	-10.4%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	7245000000.0	+5.4%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	7287000000.0	+0.6%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	7374000000.0	+1.2%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	7071000000.0	-4.1%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	7608000000.0	+7.6%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	7964000000.0	+4.7%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	8442000000.0	+6.0%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	6778000000.0	-19.7%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	8182000000.0	+20.7%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	7577000000.0	-7.4%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	8422000000.0	+11.2%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	6803000000.0	-19.2%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	8235000000.0	+21.0%	USD	10-Q	2021-05-05
Quarterly	2021-06-30	7843000000.0	-4.8%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	8571000000.0	+9.3%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	9230000000.0	+7.7%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	9828000000.0	+6.5%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	9643000000.0	-1.9%	USD	10-Q	2022-08-05
Quarterly	2022-09-30	9482000000.0	-1.7%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	9450000000.0	-0.3%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	10415000000.0	+10.2%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	11030000000.0	+5.9%	USD	10-Q	2023-08-07
Quarterly	2023-09-30	10394000000.0	-5.8%	USD	10-Q	2023-11-03
Quarterly	2023-12-31	10349000000.0	-0.4%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	11366000000.0	+9.8%	USD	10-Q	2024-05-03
Quarterly	2024-06-30	11642000000.0	+2.4%	USD	10-Q	2024-08-05
Quarterly	2024-09-30	11381000000.0	-2.2%	USD	10-Q	2024-11-06
Quarterly	2024-12-31	10278000000.0	-9.7%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	10790000000.0	+5.0%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	11846000000.0	+9.8%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	12120000000.0	+2.3%	USD	10-Q	2025-11-05
Annual	2016-12-31	7018000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	6873000000.0	-2.1%	USD	10-K	2019-02-27
Annual	2018-12-31	7071000000.0	+2.9%	USD	10-K	2020-02-26
Annual	2019-12-31	6778000000.0	-4.1%	USD	10-K	2021-02-25
Annual	2020-12-31	6803000000.0	+0.4%	USD	10-K	2022-02-25
Annual	2021-12-31	9230000000.0	+35.7%	USD	10-K	2023-02-24
Annual	2022-12-31	9450000000.0	+2.4%	USD	10-K	2024-02-26
Annual	2023-12-31	10349000000.0	+9.5%	USD	10-K	2025-02-25
Annual	2024-12-31	10278000000.0	-0.7%	USD	10-K	2026-02-24
Annual	2025-12-31	11775000000.0	+14.6%	USD	10-K	2026-02-24

Inventory

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	5102000000.0	—	USD	10-Q	2016-05-09
Quarterly	2016-06-30	5248000000.0	+2.9%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	5244000000.0	-0.1%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	4866000000.0	-7.2%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	5146000000.0	+5.8%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	5407000000.0	+5.1%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	5263000000.0	-2.7%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	5096000000.0	-3.2%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	5382000000.0	+5.6%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	5178000000.0	-3.8%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	5416000000.0	+4.6%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	5440000000.0	+0.4%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	5712000000.0	+5.0%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	5847000000.0	+2.4%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	5855000000.0	+0.1%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	5978000000.0	+2.1%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	5846000000.0	-2.2%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	6056000000.0	+3.6%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	6128000000.0	+1.2%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	5554000000.0	-9.4%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	6402000000.0	+15.3%	USD	10-Q	2021-05-05
Quarterly	2021-06-30	5499000000.0	-14.1%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	5603000000.0	+1.9%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	5953000000.0	+6.2%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	5774000000.0	-3.0%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	5535000000.0	-4.1%	USD	10-Q	2022-08-05
Quarterly	2022-09-30	5614000000.0	+1.4%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	5911000000.0	+5.3%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	5863000000.0	-0.8%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	5930000000.0	+1.1%	USD	10-Q	2023-08-07
Quarterly	2023-09-30	6131000000.0	+3.4%	USD	10-Q	2023-11-03
Quarterly	2023-12-31	6358000000.0	+3.7%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	6510000000.0	+2.4%	USD	10-Q	2024-05-03
Quarterly	2024-06-30	6469000000.0	-0.6%	USD	10-Q	2024-08-05
Quarterly	2024-09-30	6244000000.0	-3.5%	USD	10-Q	2024-11-06
Quarterly	2024-12-31	6109000000.0	-2.2%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	6196000000.0	+1.4%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	6601000000.0	+6.5%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	6444000000.0	-2.4%	USD	10-Q	2025-11-05
Annual	2016-12-31	4866000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	5096000000.0	+4.7%	USD	10-K	2019-02-27
Annual	2018-12-31	5440000000.0	+6.8%	USD	10-K	2020-02-26
Annual	2019-12-31	5978000000.0	+9.9%	USD	10-K	2021-02-25
Annual	2020-12-31	5554000000.0	-7.1%	USD	10-K	2022-02-25
Annual	2021-12-31	5953000000.0	+7.2%	USD	10-K	2023-02-24
Annual	2022-12-31	5911000000.0	-0.7%	USD	10-K	2024-02-26
Annual	2023-12-31	6358000000.0	+7.6%	USD	10-K	2025-02-25
Annual	2024-12-31	6109000000.0	-3.9%	USD	10-K	2026-02-24
Annual	2025-12-31	6658000000.0	+9.0%	USD	10-K	2026-02-24

Current Assets

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	28772000000.0	—	USD	10-Q	2016-05-09
Quarterly	2016-06-30	27926000000.0	-2.9%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	29440000000.0	+5.4%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	30614000000.0	+4.0%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	31530000000.0	+3.0%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	28167000000.0	-10.7%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	27919000000.0	-0.9%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	24766000000.0	-11.3%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	24085000000.0	-2.7%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	24064000000.0	-0.1%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	26836000000.0	+11.5%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	25875000000.0	-3.6%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	25351000000.0	-2.0%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	24298000000.0	-4.2%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	26142000000.0	+7.6%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	27483000000.0	+5.1%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	26174000000.0	-4.8%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	29343000000.0	+12.1%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	26577000000.0	-9.4%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	27764000000.0	+4.5%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	26909000000.0	-3.1%	USD	10-Q	2021-05-05
Quarterly	2021-06-30	28665000000.0	+6.5%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	31058000000.0	+8.3%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	30266000000.0	-2.6%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	31184000000.0	+3.0%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	32116000000.0	+3.0%	USD	10-Q	2022-08-05
Quarterly	2022-09-30	33561000000.0	+4.5%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	35722000000.0	+6.4%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	33402000000.0	-6.5%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	29977000000.0	-10.3%	USD	10-Q	2023-08-07
Quarterly	2023-09-30	31954000000.0	+6.6%	USD	10-Q	2023-11-03
Quarterly	2023-12-31	32168000000.0	+0.7%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	31445000000.0	-2.2%	USD	10-Q	2024-05-03
Quarterly	2024-06-30	38205000000.0	+21.5%	USD	10-Q	2024-08-05
Quarterly	2024-09-30	40361000000.0	+5.6%	USD	10-Q	2024-11-06
Quarterly	2024-12-31	38782000000.0	-3.9%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	35503000000.0	-8.5%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	37065000000.0	+4.4%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	47557000000.0	+28.3%	USD	10-Q	2025-11-05
Annual	2016-12-31	30614000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	24766000000.0	-19.1%	USD	10-K	2019-02-27
Annual	2018-12-31	25875000000.0	+4.5%	USD	10-K	2020-02-26
Annual	2019-12-31	27483000000.0	+6.2%	USD	10-K	2021-02-25
Annual	2020-12-31	27764000000.0	+1.0%	USD	10-K	2022-02-25
Annual	2021-12-31	30266000000.0	+9.0%	USD	10-K	2023-02-24
Annual	2022-12-31	35722000000.0	+18.0%	USD	10-K	2024-02-26
Annual	2023-12-31	32168000000.0	-9.9%	USD	10-K	2025-02-25
Annual	2024-12-31	38782000000.0	+20.6%	USD	10-K	2026-02-24
Annual	2025-12-31	43516000000.0	+12.2%	USD	10-K	2026-02-24

Total Assets

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	98755000000.0	—	USD	10-Q	2016-05-09
Quarterly	2016-06-30	96475000000.0	-2.3%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	98335000000.0	+1.9%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	95377000000.0	-3.0%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	96561000000.0	+1.2%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	92804000000.0	-3.9%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	91676000000.0	-1.2%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	87872000000.0	-4.1%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	86041000000.0	-2.1%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	85040000000.0	-1.2%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	85130000000.0	+0.1%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	82637000000.0	-2.9%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	82354000000.0	-0.3%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	83965000000.0	+2.0%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	83331000000.0	-0.8%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	84397000000.0	+1.3%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	84913000000.0	+0.6%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	90615000000.0	+6.7%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	89800000000.0	-0.9%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	91588000000.0	+2.0%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	90847000000.0	-0.8%	USD	10-Q	2021-05-05
Quarterly	2021-06-30	90688000000.0	-0.2%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	93494000000.0	+3.1%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	105694000000.0	+13.0%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	106668000000.0	+0.9%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	107095000000.0	+0.4%	USD	10-Q	2022-08-05
Quarterly	2022-09-30	107081000000.0	-0.0%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	109160000000.0	+1.9%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	107796000000.0	-1.2%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	104469000000.0	-3.1%	USD	10-Q	2023-08-07
Quarterly	2023-09-30	106727000000.0	+2.2%	USD	10-Q	2023-11-03
Quarterly	2023-12-31	106675000000.0	-0.0%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	105849000000.0	-0.8%	USD	10-Q	2024-05-03
Quarterly	2024-06-30	112630000000.0	+6.4%	USD	10-Q	2024-08-05
Quarterly	2024-09-30	117532000000.0	+4.4%	USD	10-Q	2024-11-06
Quarterly	2024-12-31	117106000000.0	-0.4%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	115122000000.0	-1.7%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	117523000000.0	+2.1%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	129546000000.0	+10.2%	USD	10-Q	2025-11-05
Annual	2016-12-31	95377000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	87872000000.0	-7.9%	USD	10-K	2019-02-27
Annual	2018-12-31	82637000000.0	-6.0%	USD	10-K	2020-02-26
Annual	2019-12-31	84397000000.0	+2.1%	USD	10-K	2021-02-25
Annual	2020-12-31	91588000000.0	+8.5%	USD	10-K	2022-02-25
Annual	2021-12-31	105694000000.0	+15.4%	USD	10-K	2023-02-24
Annual	2022-12-31	109160000000.0	+3.3%	USD	10-K	2024-02-26
Annual	2023-12-31	106675000000.0	-2.3%	USD	10-K	2025-02-25
Annual	2024-12-31	117106000000.0	+9.8%	USD	10-K	2026-02-24
Annual	2025-12-31	136866000000.0	+16.9%	USD	10-K	2026-02-24

Current Liabilities

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	17568000000.0	—	USD	10-Q	2016-05-09
Quarterly	2016-06-30	14918000000.0	-15.1%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	15555000000.0	+4.3%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	17204000000.0	+10.6%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	19823000000.0	+15.2%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	18758000000.0	-5.4%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	19467000000.0	+3.8%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	18614000000.0	-4.4%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	16960000000.0	-8.9%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	18128000000.0	+6.9%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	18586000000.0	+2.5%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	22206000000.0	+19.5%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	18543000000.0	-16.5%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	20085000000.0	+8.3%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	20684000000.0	+3.0%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	22220000000.0	+7.4%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	23483000000.0	+5.7%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	22178000000.0	-5.6%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	20405000000.0	-8.0%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	27327000000.0	+33.9%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	26361000000.0	-3.5%	USD	10-Q	2021-05-05
Quarterly	2021-06-30	21906000000.0	-16.9%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	23728000000.0	+8.3%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	23872000000.0	+0.6%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	22316000000.0	-6.5%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	23168000000.0	+3.8%	USD	10-Q	2022-08-05
Quarterly	2022-09-30	22998000000.0	-0.7%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	24239000000.0	+5.4%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	23131000000.0	-4.6%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	23394000000.0	+1.1%	USD	10-Q	2023-08-07
Quarterly	2023-09-30	23094000000.0	-1.3%	USD	10-Q	2023-11-03
Quarterly	2023-12-31	25694000000.0	+11.3%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	25099000000.0	-2.3%	USD	10-Q	2024-05-03
Quarterly	2024-06-30	26060000000.0	+3.8%	USD	10-Q	2024-08-05
Quarterly	2024-09-30	29586000000.0	+13.5%	USD	10-Q	2024-11-06
Quarterly	2024-12-31	28420000000.0	-3.9%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	25174000000.0	-11.4%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	26037000000.0	+3.4%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	28628000000.0	+10.0%	USD	10-Q	2025-11-05
Annual	2016-12-31	17204000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	18614000000.0	+8.2%	USD	10-K	2019-02-27
Annual	2018-12-31	22206000000.0	+19.3%	USD	10-K	2020-02-26
Annual	2019-12-31	22220000000.0	+0.1%	USD	10-K	2021-02-25
Annual	2020-12-31	27327000000.0	+23.0%	USD	10-K	2022-02-25
Annual	2021-12-31	23872000000.0	-12.6%	USD	10-K	2023-02-24
Annual	2022-12-31	24239000000.0	+1.5%	USD	10-K	2024-02-26
Annual	2023-12-31	25694000000.0	+6.0%	USD	10-K	2025-02-25
Annual	2024-12-31	28420000000.0	+10.6%	USD	10-K	2026-02-24
Annual	2025-12-31	28327000000.0	-0.3%	USD	10-K	2026-02-24

Total Liabilities

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Stockholders' Equity

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	43901000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	43446000000.0	-1.0%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	43957000000.0	+1.2%	USD	10-Q	2017-11-07
Quarterly	2016-12-31	40308000000.0	-8.3%	USD	10-Q	2018-11-06
Quarterly	2017-03-31	40088000000.0	-0.5%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	39712000000.0	-0.9%	USD	10-Q	2018-11-06
Quarterly	2017-09-30	38499000000.0	-3.1%	USD	10-Q	2018-11-06
Quarterly	2017-12-31	34569000000.0	-10.2%	USD	10-Q	2019-11-05
Quarterly	2018-03-31	33901000000.0	-1.9%	USD	10-Q	2019-08-06
Quarterly	2018-06-30	32766000000.0	-3.3%	USD	10-Q	2019-11-05
Quarterly	2018-09-30	32656000000.0	-0.3%	USD	10-Q	2019-11-05
Quarterly	2018-12-31	26882000000.0	-17.7%	USD	10-Q	2020-11-05
Quarterly	2019-03-31	27670000000.0	+2.9%	USD	10-Q	2020-08-05
Quarterly	2019-06-30	27737000000.0	+0.2%	USD	10-Q	2020-11-05
Quarterly	2019-09-30	26925000000.0	-2.9%	USD	10-Q	2020-11-05
Quarterly	2019-12-31	26001000000.0	-3.4%	USD	10-Q	2021-11-05
Quarterly	2020-03-31	26300000000.0	+1.1%	USD	10-Q	2021-08-09
Quarterly	2020-06-30	27744000000.0	+5.5%	USD	10-Q	2021-11-05
Quarterly	2020-09-30	29270000000.0	+5.5%	USD	10-Q	2021-11-05
Quarterly	2020-12-31	25404000000.0	-13.2%	USD	10-Q	2022-11-03
Quarterly	2021-03-31	27039000000.0	+6.4%	USD	10-Q	2022-08-05
Quarterly	2021-06-30	33388000000.0	+23.5%	USD	10-Q	2022-11-03
Quarterly	2021-09-30	35863000000.0	+7.4%	USD	10-Q	2022-11-03
Quarterly	2021-12-31	38257000000.0	+6.7%	USD	10-Q	2023-11-03
Quarterly	2022-03-31	40953000000.0	+7.0%	USD	10-Q	2023-08-07
Quarterly	2022-06-30	43318000000.0	+5.8%	USD	10-Q	2023-11-03
Quarterly	2022-09-30	44524000000.0	+2.8%	USD	10-Q	2023-11-03
Quarterly	2022-12-31	46058000000.0	+3.4%	USD	10-Q	2024-11-06
Quarterly	2023-03-31	46905000000.0	+1.8%	USD	10-Q	2024-08-05
Quarterly	2023-06-30	38742000000.0	-17.4%	USD	10-Q	2024-11-06
Quarterly	2023-09-30	41300000000.0	+6.6%	USD	10-Q	2024-11-06
Quarterly	2023-12-31	37635000000.0	-8.9%	USD	10-Q	2025-11-05
Quarterly	2024-03-31	40424000000.0	+7.4%	USD	10-Q	2025-08-05
Quarterly	2024-06-30	43648000000.0	+8.0%	USD	10-Q	2025-11-05
Quarterly	2024-09-30	44560000000.0	+2.1%	USD	10-Q	2025-11-05
Quarterly	2024-12-31	46372000000.0	+4.1%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	48400000000.0	+4.4%	USD	10-Q	2025-08-05
Quarterly	2025-06-30	49060000000.0	+1.4%	USD	10-Q	2025-11-05
Quarterly	2025-09-30	51907000000.0	+5.8%	USD	10-Q	2025-11-05
Annual	2016-12-31	40308000000.0	—	USD	10-K	2020-02-26
Annual	2017-12-31	34569000000.0	-14.2%	USD	10-K	2021-02-25
Annual	2018-12-31	26882000000.0	-22.2%	USD	10-K	2022-02-25
Annual	2019-12-31	26001000000.0	-3.3%	USD	10-K	2023-02-24
Annual	2020-12-31	25404000000.0	-2.3%	USD	10-K	2024-02-26
Annual	2021-12-31	38257000000.0	+50.6%	USD	10-K	2025-02-25
Annual	2022-12-31	46058000000.0	+20.4%	USD	10-K	2026-02-24
Annual	2023-12-31	37635000000.0	-18.3%	USD	10-K	2026-02-24
Annual	2024-12-31	46372000000.0	+23.2%	USD	10-K	2026-02-24
Annual	2025-12-31	52662000000.0	+13.6%	USD	10-K	2026-02-24

Long-Term Debt

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	23656000000.0	—	USD	10-Q	2016-05-09
Quarterly	2016-06-30	23642000000.0	-0.1%	USD	10-Q	2016-08-08
Quarterly	2016-09-30	23656000000.0	+0.1%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	24274000000.0	+2.6%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	23437000000.0	-3.4%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	21706000000.0	-7.4%	USD	10-Q	2017-08-08
Quarterly	2017-09-30	21838000000.0	+0.6%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	21353000000.0	-2.2%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	21501000000.0	+0.7%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	19959000000.0	-7.2%	USD	10-Q	2018-08-07
Quarterly	2018-09-30	19936000000.0	-0.1%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	19806000000.0	-0.7%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	22721000000.0	+14.7%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	22771000000.0	+0.2%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	22677000000.0	-0.4%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	22736000000.0	+0.3%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	21637000000.0	-4.8%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	26156000000.0	+20.9%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	26321000000.0	+0.6%	USD	10-Q	2020-11-05
Quarterly	2020-12-31	25360000000.0	-3.7%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	24002000000.0	-5.4%	USD	10-Q	2021-05-05
Quarterly	2021-06-30	24033000000.0	+0.1%	USD	10-Q	2021-08-09
Quarterly	2021-09-30	22907000000.0	-4.7%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	30690000000.0	+34.0%	USD	10-Q	2022-11-03
Quarterly	2022-03-31	30586000000.0	-0.3%	USD	10-Q	2022-05-05
Quarterly	2022-06-30	28684000000.0	-6.2%	USD	10-Q	2022-08-05
Quarterly	2022-09-30	28482000000.0	-0.7%	USD	10-Q	2022-11-03
Quarterly	2022-12-31	28745000000.0	+0.9%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	28074000000.0	-2.3%	USD	10-Q	2023-05-05
Quarterly	2023-06-30	34072000000.0	+21.4%	USD	10-Q	2023-08-07
Quarterly	2023-09-30	33972000000.0	-0.3%	USD	10-Q	2023-11-03
Quarterly	2023-12-31	33683000000.0	-0.9%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	31142000000.0	-7.5%	USD	10-Q	2024-05-03
Quarterly	2024-06-30	34717000000.0	+11.5%	USD	10-Q	2024-08-05
Quarterly	2024-09-30	34982000000.0	+0.8%	USD	10-Q	2024-11-06
Quarterly	2024-12-31	34462000000.0	-1.5%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	33484000000.0	-2.8%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	33968000000.0	+1.4%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	39969000000.0	+17.7%	USD	10-Q	2025-11-05
Annual	2016-12-31	24274000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	21353000000.0	-12.0%	USD	10-K	2019-02-27
Annual	2018-12-31	19806000000.0	-7.2%	USD	10-K	2020-02-26
Annual	2019-12-31	22736000000.0	+14.8%	USD	10-K	2021-02-25
Annual	2020-12-31	25360000000.0	+11.5%	USD	10-K	2022-02-25
Annual	2021-12-31	30690000000.0	+21.0%	USD	10-K	2023-02-24
Annual	2022-12-31	28745000000.0	-6.3%	USD	10-K	2024-02-26
Annual	2023-12-31	33683000000.0	+17.2%	USD	10-K	2025-02-25
Annual	2024-12-31	34462000000.0	+2.3%	USD	10-K	2026-02-24
Annual	2025-12-31	46750000000.0	+35.7%	USD	10-K	2026-02-24

Cash Flow

Metrics: 4

Operating Cash Flow

Q: 28 | A: 9

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	2173000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	3773000000.0	+73.6%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	6744000000.0	+78.7%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	286000000.0	-95.8%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	3603000000.0	+1159.8%	USD	10-Q	2018-08-07
Quarterly	2017-09-30	2432000000.0	-32.5%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	1155000000.0	-52.5%	USD	10-Q	2019-05-08
Quarterly	2018-06-30	4537000000.0	+292.8%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	7330000000.0	+61.6%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	1336000000.0	-81.8%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	4420000000.0	+230.8%	USD	10-Q	2020-08-05
Quarterly	2019-09-30	8646000000.0	+95.6%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	707000000.0	-91.8%	USD	10-Q	2021-05-05
Quarterly	2020-06-30	4074000000.0	+476.2%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	6247000000.0	+53.3%	USD	10-Q	2020-11-05
Quarterly	2021-03-31	1791000000.0	-71.3%	USD	10-Q	2021-05-05
Quarterly	2022-03-31	4761000000.0	+165.8%	USD	10-Q	2023-05-05
Quarterly	2022-06-30	9063000000.0	+90.4%	USD	10-Q	2023-08-07
Quarterly	2022-09-30	14665000000.0	+61.8%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	1339000000.0	-90.9%	USD	10-Q	2024-05-03
Quarterly	2023-06-30	5043000000.0	+276.6%	USD	10-Q	2024-08-05
Quarterly	2023-09-30	12760000000.0	+153.0%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	3090000000.0	-75.8%	USD	10-Q	2025-05-02
Quarterly	2024-06-30	8727000000.0	+182.4%	USD	10-Q	2025-08-05
Quarterly	2024-09-30	18018000000.0	+106.5%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	2500000000.0	-86.1%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	5793000000.0	+131.7%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	13615000000.0	+135.0%	USD	10-Q	2025-11-05
Annual	2016-12-31	10376000000.0	—	USD	10-K	2019-02-27
Annual	2017-12-31	6451000000.0	-37.8%	USD	10-K	2020-02-26
Annual	2018-12-31	10922000000.0	+69.3%	USD	10-K	2021-02-25
Annual	2019-12-31	13440000000.0	+23.1%	USD	10-K	2021-02-25
Annual	2020-12-31	10253000000.0	-23.7%	USD	10-K	2021-02-25
Annual	2022-12-31	19095000000.0	+86.2%	USD	10-K	2025-02-25
Annual	2023-12-31	13006000000.0	-31.9%	USD	10-K	2026-02-24
Annual	2024-12-31	21468000000.0	+65.1%	USD	10-K	2026-02-24
Annual	2025-12-31	16472000000.0	-23.3%	USD	10-K	2026-02-24

Investing Cash Flow

Q: 28 | A: 9

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1741000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	243000000.0	-86.0%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	-647000000.0	-366.3%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	3193000000.0	+593.5%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	2066000000.0	-35.3%	USD	10-Q	2018-08-07
Quarterly	2017-09-30	2737000000.0	+32.5%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	-197000000.0	-107.2%	USD	10-Q	2019-05-08
Quarterly	2018-06-30	476000000.0	+341.6%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	2136000000.0	+348.7%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	368000000.0	-82.8%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	-2057000000.0	-659.0%	USD	10-Q	2020-08-05
Quarterly	2019-09-30	-1866000000.0	+9.3%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	-1628000000.0	+12.8%	USD	10-Q	2021-05-05
Quarterly	2020-06-30	-2510000000.0	-54.2%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	-4665000000.0	-85.9%	USD	10-Q	2020-11-05
Quarterly	2021-03-31	-738000000.0	+84.2%	USD	10-Q	2021-05-05
Quarterly	2022-03-31	-1173000000.0	-58.9%	USD	10-Q	2023-05-05
Quarterly	2022-06-30	-2250000000.0	-91.8%	USD	10-Q	2023-08-07
Quarterly	2022-09-30	-3212000000.0	-42.8%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	-2359000000.0	+26.6%	USD	10-Q	2024-05-03
Quarterly	2023-06-30	-13802000000.0	-485.1%	USD	10-Q	2024-08-05
Quarterly	2023-09-30	-14136000000.0	-2.4%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	-1376000000.0	+90.3%	USD	10-Q	2025-05-02
Quarterly	2024-06-30	-2445000000.0	-77.7%	USD	10-Q	2025-08-05
Quarterly	2024-09-30	-6290000000.0	-157.3%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	-1487000000.0	+76.4%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	-2257000000.0	-51.8%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	-2540000000.0	-12.5%	USD	10-Q	2025-11-05
Annual	2016-12-31	-3210000000.0	—	USD	10-K	2019-02-27
Annual	2017-12-31	2679000000.0	+183.5%	USD	10-K	2020-02-26
Annual	2018-12-31	4314000000.0	+61.0%	USD	10-K	2021-02-25
Annual	2019-12-31	-2629000000.0	-160.9%	USD	10-K	2021-02-25
Annual	2020-12-31	-9443000000.0	-259.2%	USD	10-K	2021-02-25
Annual	2022-12-31	-4960000000.0	+47.5%	USD	10-K	2025-02-25
Annual	2023-12-31	-14083000000.0	-183.9%	USD	10-K	2026-02-24
Annual	2024-12-31	-7734000000.0	+45.1%	USD	10-K	2026-02-24
Annual	2025-12-31	-13741000000.0	-77.7%	USD	10-K	2026-02-24

Financing Cash Flow

Q: 28 | A: 9

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	-2866000000.0	—	USD	10-Q	2017-05-09
Quarterly	2016-06-30	-6232000000.0	-117.4%	USD	10-Q	2017-08-08
Quarterly	2016-09-30	-7067000000.0	-13.4%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	1461000000.0	+120.7%	USD	10-Q	2018-05-08
Quarterly	2017-06-30	-4757000000.0	-425.6%	USD	10-Q	2018-08-07
Quarterly	2017-09-30	-4221000000.0	+11.3%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	-2722000000.0	+35.5%	USD	10-Q	2019-05-08
Quarterly	2018-06-30	-5689000000.0	-109.0%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	-7594000000.0	-33.5%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	-1614000000.0	+78.7%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	-3698000000.0	-129.1%	USD	10-Q	2020-08-05
Quarterly	2019-09-30	-6850000000.0	-85.2%	USD	10-Q	2020-11-05
Quarterly	2020-03-31	-1490000000.0	+78.2%	USD	10-Q	2021-05-05
Quarterly	2020-06-30	-353000000.0	+76.3%	USD	10-Q	2020-08-05
Quarterly	2020-09-30	-4204000000.0	-1090.9%	USD	10-Q	2020-11-05
Quarterly	2021-03-31	-2098000000.0	+50.1%	USD	10-Q	2022-05-05
Quarterly	2022-03-31	-3086000000.0	-47.1%	USD	10-Q	2023-05-05
Quarterly	2022-06-30	-4863000000.0	-57.6%	USD	10-Q	2023-08-07
Quarterly	2022-09-30	-7565000000.0	-55.6%	USD	10-Q	2023-11-03
Quarterly	2023-03-31	-2054000000.0	+72.8%	USD	10-Q	2024-05-03
Quarterly	2023-06-30	1704000000.0	+183.0%	USD	10-Q	2024-08-05
Quarterly	2023-09-30	-2565000000.0	-250.5%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	-2814000000.0	-9.7%	USD	10-Q	2025-05-02
Quarterly	2024-06-30	-1598000000.0	+43.2%	USD	10-Q	2025-08-05
Quarterly	2024-09-30	-4023000000.0	-151.8%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	-5755000000.0	-43.1%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	-9311000000.0	-61.8%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	-6673000000.0	+28.3%	USD	10-Q	2025-11-05
Annual	2016-12-31	-9044000000.0	—	USD	10-K	2019-02-27
Annual	2017-12-31	-10006000000.0	-10.6%	USD	10-K	2020-02-26
Annual	2018-12-31	-13160000000.0	-31.5%	USD	10-K	2021-02-25
Annual	2019-12-31	-8861000000.0	+32.7%	USD	10-K	2021-02-25
Annual	2020-12-31	-2832000000.0	+68.0%	USD	10-K	2021-02-25
Annual	2022-12-31	-9119000000.0	-222.0%	USD	10-K	2025-02-25
Annual	2023-12-31	-4810000000.0	+47.3%	USD	10-K	2026-02-24
Annual	2024-12-31	-7032000000.0	-46.2%	USD	10-K	2026-02-24
Annual	2025-12-31	-1922000000.0	+72.7%	USD	10-K	2026-02-24

Capital Expenditures

Q: 10 | A: 5

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2022-09-30	3239000000.0	—	USD	10-Q	2023-11-03
Quarterly	2023-03-31	1007000000.0	-68.9%	USD	10-Q	2024-05-03
Quarterly	2023-06-30	1972000000.0	+95.8%	USD	10-Q	2024-08-05
Quarterly	2023-09-30	2874000000.0	+45.7%	USD	10-Q	2024-11-06
Quarterly	2024-03-31	861000000.0	-70.0%	USD	10-Q	2025-05-02
Quarterly	2024-06-30	1652000000.0	+91.9%	USD	10-Q	2025-08-05
Quarterly	2024-09-30	2435000000.0	+47.4%	USD	10-Q	2025-11-05
Quarterly	2025-03-31	1328000000.0	-45.5%	USD	10-Q	2025-05-02
Quarterly	2025-06-30	2092000000.0	+57.5%	USD	10-Q	2025-08-05
Quarterly	2025-09-30	3079000000.0	+47.2%	USD	10-Q	2025-11-05
Annual	2021-12-31	4448000000.0	—	USD	10-K	2024-02-26
Annual	2022-12-31	4388000000.0	-1.3%	USD	10-K	2025-02-25
Annual	2023-12-31	3863000000.0	-12.0%	USD	10-K	2026-02-24
Annual	2024-12-31	3372000000.0	-12.7%	USD	10-K	2026-02-24
Annual	2025-12-31	4112000000.0	+21.9%	USD	10-K	2026-02-24

Share Data

Metrics: 4

Shares Outstanding

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Shares Issued

Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	3577103522.0	—	shares	10-Q	2016-05-09
Quarterly	2016-06-30	3577103522.0	+0.0%	shares	10-Q	2016-08-08
Quarterly	2016-09-30	3577103522.0	+0.0%	shares	10-Q	2016-11-07
Quarterly	2016-12-31	3577103522.0	+0.0%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	3577103522.0	+0.0%	shares	10-Q	2017-05-09
Quarterly	2017-06-30	3577103522.0	+0.0%	shares	10-Q	2017-08-08
Quarterly	2017-09-30	3577103522.0	+0.0%	shares	10-Q	2017-11-07
Quarterly	2017-12-31	3577103522.0	+0.0%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	3577103522.0	+0.0%	shares	10-Q	2018-05-08
Quarterly	2018-06-30	3577103522.0	+0.0%	shares	10-Q	2018-08-07
Quarterly	2018-09-30	3577103522.0	+0.0%	shares	10-Q	2018-11-06
Quarterly	2018-12-31	3577103522.0	+0.0%	shares	10-Q	2019-11-05
Quarterly	2019-03-31	3577103522.0	+0.0%	shares	10-Q	2019-05-08
Quarterly	2019-06-30	3577103522.0	+0.0%	shares	10-Q	2019-08-06
Quarterly	2019-09-30	3577103522.0	+0.0%	shares	10-Q	2019-11-05
Quarterly	2019-12-31	3577103522.0	+0.0%	shares	10-Q	2020-11-05
Quarterly	2020-03-31	3577103522.0	+0.0%	shares	10-Q	2020-05-06
Quarterly	2020-06-30	3577103522.0	+0.0%	shares	10-Q	2020-08-05
Quarterly	2020-09-30	3577103522.0	+0.0%	shares	10-Q	2020-11-05
Quarterly	2020-12-31	3577103522.0	+0.0%	shares	10-Q	2021-11-05
Quarterly	2021-03-31	3577103522.0	+0.0%	shares	10-Q	2021-05-05
Quarterly	2021-06-30	3577103522.0	+0.0%	shares	10-Q	2021-08-09
Quarterly	2021-09-30	3577103522.0	+0.0%	shares	10-Q	2021-11-05
Quarterly	2021-12-31	3577103522.0	+0.0%	shares	10-Q	2022-11-03
Quarterly	2022-03-31	3577103522.0	+0.0%	shares	10-Q	2022-05-05
Quarterly	2022-06-30	3577103522.0	+0.0%	shares	10-Q	2022-08-05
Quarterly	2022-09-30	3577103522.0	+0.0%	shares	10-Q	2022-11-03
Quarterly	2022-12-31	3577103522.0	+0.0%	shares	10-Q	2023-11-03
Quarterly	2023-03-31	3577103522.0	+0.0%	shares	10-Q	2023-05-05
Quarterly	2023-06-30	3577103522.0	+0.0%	shares	10-Q	2023-08-07
Quarterly	2023-09-30	3577103522.0	+0.0%	shares	10-Q	2023-11-03
Quarterly	2023-12-31	3577103522.0	+0.0%	shares	10-Q	2024-11-06
Quarterly	2024-03-31	3577103522.0	+0.0%	shares	10-Q	2024-05-03
Quarterly	2024-06-30	3577103522.0	+0.0%	shares	10-Q	2024-08-05
Quarterly	2024-09-30	3577103522.0	+0.0%	shares	10-Q	2024-11-06
Quarterly	2024-12-31	3577103522.0	+0.0%	shares	10-Q	2025-11-05
Quarterly	2025-03-31	3577103522.0	+0.0%	shares	10-Q	2025-05-02
Quarterly	2025-06-30	3577103522.0	+0.0%	shares	10-Q	2025-08-05
Quarterly	2025-09-30	3577103522.0	+0.0%	shares	10-Q	2025-11-05
Annual	2016-12-31	3577103522.0	—	shares	10-K	2018-02-27
Annual	2017-12-31	3577103522.0	+0.0%	shares	10-K	2019-02-27
Annual	2018-12-31	3577103522.0	+0.0%	shares	10-K	2020-02-26
Annual	2019-12-31	3577103522.0	+0.0%	shares	10-K	2021-02-25
Annual	2020-12-31	3577103522.0	+0.0%	shares	10-K	2022-02-25
Annual	2021-12-31	3577103522.0	+0.0%	shares	10-K	2023-02-24
Annual	2022-12-31	3577103522.0	+0.0%	shares	10-K	2024-02-26
Annual	2023-12-31	3577103522.0	+0.0%	shares	10-K	2025-02-25
Annual	2024-12-31	3577103522.0	+0.0%	shares	10-K	2026-02-24
Annual	2025-12-31	3577103522.0	+0.0%	shares	10-K	2026-02-24

Weighted Avg Shares Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	2774000000.0	—	shares	10-Q	2017-05-09
Quarterly	2016-06-30	2768000000.0	-0.2%	shares	10-Q	2017-08-08
Quarterly	2016-09-30	2765000000.0	-0.1%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	2745000000.0	-0.7%	shares	10-Q	2018-05-08
Quarterly	2017-06-30	2734000000.0	-0.4%	shares	10-Q	2018-08-07
Quarterly	2017-09-30	2727000000.0	-0.3%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	2695000000.0	-1.2%	shares	10-Q	2019-05-08
Quarterly	2018-06-30	2683000000.0	-0.4%	shares	10-Q	2019-08-06
Quarterly	2018-09-30	2662000000.0	-0.8%	shares	10-Q	2019-11-05
Quarterly	2019-03-31	2585000000.0	-2.9%	shares	10-Q	2020-05-06
Quarterly	2019-06-30	2574000000.0	-0.4%	shares	10-Q	2020-08-05
Quarterly	2019-09-30	2558000000.0	-0.6%	shares	10-Q	2020-11-05
Quarterly	2020-03-31	2533000000.0	-1.0%	shares	10-Q	2021-05-05
Quarterly	2020-06-30	2527000000.0	-0.2%	shares	10-Q	2021-08-09
Quarterly	2020-09-30	2529000000.0	+0.1%	shares	10-Q	2021-11-05
Quarterly	2021-03-31	2531000000.0	+0.1%	shares	10-Q	2022-05-05
Quarterly	2021-06-30	2533000000.0	+0.1%	shares	10-Q	2022-08-05
Quarterly	2021-09-30	2530000000.0	-0.1%	shares	10-Q	2022-11-03
Quarterly	2022-03-31	2528000000.0	-0.1%	shares	10-Q	2023-05-05
Quarterly	2022-06-30	2531000000.0	+0.1%	shares	10-Q	2023-08-07
Quarterly	2022-09-30	2533000000.0	+0.1%	shares	10-Q	2023-11-03
Quarterly	2023-03-31	2538000000.0	+0.2%	shares	10-Q	2024-05-03
Quarterly	2023-06-30	2539000000.0	+0.0%	shares	10-Q	2024-08-05
Quarterly	2023-09-30	2537000000.0	-0.1%	shares	10-Q	2024-11-06
Quarterly	2024-03-31	2533000000.0	-0.2%	shares	10-Q	2025-05-02
Quarterly	2024-06-30	2534000000.0	+0.0%	shares	10-Q	2025-08-05
Quarterly	2024-09-30	2534000000.0	+0.0%	shares	10-Q	2025-11-05
Quarterly	2025-03-31	2523000000.0	-0.4%	shares	10-Q	2025-05-02
Quarterly	2025-06-30	2510000000.0	-0.5%	shares	10-Q	2025-08-05
Quarterly	2025-09-30	2495000000.0	-0.6%	shares	10-Q	2025-11-05
Annual	2016-12-31	2766000000.0	—	shares	10-K	2019-02-27
Annual	2017-12-31	2730000000.0	-1.3%	shares	10-K	2020-02-26
Annual	2018-12-31	2664000000.0	-2.4%	shares	10-K	2021-02-25
Annual	2019-12-31	2565000000.0	-3.7%	shares	10-K	2022-02-25
Annual	2020-12-31	2530000000.0	-1.4%	shares	10-K	2023-02-24
Annual	2021-12-31	2530000000.0	+0.0%	shares	10-K	2024-02-26
Annual	2022-12-31	2532000000.0	+0.1%	shares	10-K	2025-02-25
Annual	2023-12-31	2537000000.0	+0.2%	shares	10-K	2026-02-24
Annual	2024-12-31	2532000000.0	-0.2%	shares	10-K	2026-02-24
Annual	2025-12-31	2502000000.0	-1.2%	shares	10-K	2026-02-24

Weighted Avg Shares Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	2795000000.0	—	shares	10-Q	2017-05-09
Quarterly	2016-06-30	2789000000.0	-0.2%	shares	10-Q	2017-08-08
Quarterly	2016-09-30	2786000000.0	-0.1%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	2766000000.0	-0.7%	shares	10-Q	2018-05-08
Quarterly	2017-06-30	2752000000.0	-0.5%	shares	10-Q	2018-08-07
Quarterly	2017-09-30	2727000000.0	-0.9%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	2710000000.0	-0.6%	shares	10-Q	2019-05-08
Quarterly	2018-06-30	2696000000.0	-0.5%	shares	10-Q	2019-08-06
Quarterly	2018-09-30	2678000000.0	-0.7%	shares	10-Q	2019-11-05
Quarterly	2019-03-31	2603000000.0	-2.8%	shares	10-Q	2020-05-06
Quarterly	2019-06-30	2588000000.0	-0.6%	shares	10-Q	2020-08-05
Quarterly	2019-09-30	2572000000.0	-0.6%	shares	10-Q	2020-11-05
Quarterly	2020-03-31	2547000000.0	-1.0%	shares	10-Q	2021-05-05
Quarterly	2020-06-30	2536000000.0	-0.4%	shares	10-Q	2021-08-09
Quarterly	2020-09-30	2538000000.0	+0.1%	shares	10-Q	2021-11-05
Quarterly	2021-03-31	2541000000.0	+0.1%	shares	10-Q	2022-05-05
Quarterly	2021-06-30	2540000000.0	-0.0%	shares	10-Q	2022-08-05
Quarterly	2021-09-30	2536000000.0	-0.2%	shares	10-Q	2022-11-03
Quarterly	2022-03-31	2537000000.0	+0.0%	shares	10-Q	2023-05-05
Quarterly	2022-06-30	2540000000.0	+0.1%	shares	10-Q	2023-08-07
Quarterly	2022-09-30	2542000000.0	+0.1%	shares	10-Q	2023-11-03
Quarterly	2023-03-31	2551000000.0	+0.4%	shares	10-Q	2024-05-03
Quarterly	2023-06-30	2539000000.0	-0.5%	shares	10-Q	2024-08-05
Quarterly	2023-09-30	2546000000.0	+0.3%	shares	10-Q	2024-11-06
Quarterly	2024-03-31	2544000000.0	-0.1%	shares	10-Q	2025-05-02
Quarterly	2024-06-30	2544000000.0	+0.0%	shares	10-Q	2025-08-05
Quarterly	2024-09-30	2541000000.0	-0.1%	shares	10-Q	2025-11-05
Quarterly	2025-03-31	2531000000.0	-0.4%	shares	10-Q	2025-05-02
Quarterly	2025-06-30	2513000000.0	-0.7%	shares	10-Q	2025-08-05
Quarterly	2025-09-30	2498000000.0	-0.6%	shares	10-Q	2025-11-05
Annual	2016-12-31	2787000000.0	—	shares	10-K	2019-02-27
Annual	2017-12-31	2748000000.0	-1.4%	shares	10-K	2020-02-26
Annual	2018-12-31	2679000000.0	-2.5%	shares	10-K	2021-02-25
Annual	2019-12-31	2580000000.0	-3.7%	shares	10-K	2022-02-25
Annual	2020-12-31	2541000000.0	-1.5%	shares	10-K	2023-02-24
Annual	2021-12-31	2538000000.0	-0.1%	shares	10-K	2024-02-26
Annual	2022-12-31	2542000000.0	+0.2%	shares	10-K	2025-02-25
Annual	2023-12-31	2547000000.0	+0.2%	shares	10-K	2026-02-24
Annual	2024-12-31	2541000000.0	-0.2%	shares	10-K	2026-02-24
Annual	2025-12-31	2507000000.0	-1.3%	shares	10-K	2026-02-24

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

46,750,000,000

Total Liabilities (latest annual)

N/A

Current Liabilities (latest annual)

28,327,000,000

Metrics

Metrics: 6

Asset Turnover

Efficiency Q: 26 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-06-30	0.1070	—	ratio	10-Q	2018-08-07
Quarterly	2017-09-30	0.1126	+5.3%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.1167	+3.6%	ratio	10-Q	2019-05-08
Quarterly	2018-06-30	0.1231	+5.5%	ratio	10-Q	2019-08-06
Quarterly	2018-09-30	0.1268	+3.0%	ratio	10-Q	2019-11-05
Quarterly	2019-03-31	0.1313	+3.6%	ratio	10-Q	2020-05-06
Quarterly	2019-06-30	0.1401	+6.6%	ratio	10-Q	2020-08-05
Quarterly	2019-09-30	0.1488	+6.2%	ratio	10-Q	2020-11-05
Quarterly	2020-03-31	0.1420	-4.6%	ratio	10-Q	2021-05-05
Quarterly	2020-06-30	0.1032	-27.3%	ratio	10-Q	2021-08-09
Quarterly	2020-09-30	0.1217	+17.9%	ratio	10-Q	2021-11-05
Quarterly	2021-03-31	0.1170	-3.9%	ratio	10-Q	2022-05-05
Quarterly	2021-06-30	0.1257	+7.5%	ratio	10-Q	2022-08-05
Quarterly	2021-09-30	0.1407	+11.9%	ratio	10-Q	2022-11-03
Quarterly	2022-03-31	0.1491	+6.0%	ratio	10-Q	2023-05-05
Quarterly	2022-06-30	0.1363	-8.6%	ratio	10-Q	2023-08-07
Quarterly	2022-09-30	0.1397	+2.5%	ratio	10-Q	2023-11-03
Quarterly	2023-03-31	0.1344	-3.8%	ratio	10-Q	2024-05-03
Quarterly	2023-06-30	0.1439	+7.1%	ratio	10-Q	2024-08-05
Quarterly	2023-09-30	0.1496	+3.9%	ratio	10-Q	2024-11-06
Quarterly	2024-03-31	0.1490	-0.4%	ratio	10-Q	2025-05-02
Quarterly	2024-06-30	0.1431	-4.0%	ratio	10-Q	2025-08-05
Quarterly	2024-09-30	0.1417	-0.9%	ratio	10-Q	2025-11-05
Quarterly	2025-03-31	0.1349	-4.8%	ratio	10-Q	2025-05-02
Quarterly	2025-06-30	0.1345	-0.3%	ratio	10-Q	2025-08-05
Quarterly	2025-09-30	0.1334	-0.8%	ratio	10-Q	2025-11-05
Annual	2016-12-31	0.4174	—	ratio	10-K	2019-02-27
Annual	2017-12-31	0.4566	+9.4%	ratio	10-K	2020-02-26
Annual	2018-12-31	0.5118	+12.1%	ratio	10-K	2021-02-25
Annual	2019-12-31	0.4635	-9.4%	ratio	10-K	2022-02-25
Annual	2020-12-31	0.4533	-2.2%	ratio	10-K	2023-02-24
Annual	2021-12-31	0.4608	+1.7%	ratio	10-K	2024-02-26
Annual	2022-12-31	0.5431	+17.9%	ratio	10-K	2025-02-25
Annual	2023-12-31	0.5635	+3.8%	ratio	10-K	2026-02-24
Annual	2024-12-31	0.5479	-2.8%	ratio	10-K	2026-02-24
Annual	2025-12-31	0.4750	-13.3%	ratio	10-K	2026-02-24

Current Ratio

Liquidity Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1.6378	—	ratio	10-Q	2016-05-09
Quarterly	2016-06-30	1.8720	+14.3%	ratio	10-Q	2016-08-08
Quarterly	2016-09-30	1.8926	+1.1%	ratio	10-Q	2016-11-07
Quarterly	2016-12-31	1.7795	-6.0%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	1.5906	-10.6%	ratio	10-Q	2017-05-09
Quarterly	2017-06-30	1.5016	-5.6%	ratio	10-Q	2017-08-08
Quarterly	2017-09-30	1.4342	-4.5%	ratio	10-Q	2017-11-07
Quarterly	2017-12-31	1.3305	-7.2%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	1.4201	+6.7%	ratio	10-Q	2018-05-08
Quarterly	2018-06-30	1.3274	-6.5%	ratio	10-Q	2018-08-07
Quarterly	2018-09-30	1.4439	+8.8%	ratio	10-Q	2018-11-06
Quarterly	2018-12-31	1.1652	-19.3%	ratio	10-Q	2019-11-05
Quarterly	2019-03-31	1.3671	+17.3%	ratio	10-Q	2019-05-08
Quarterly	2019-06-30	1.2098	-11.5%	ratio	10-Q	2019-08-06
Quarterly	2019-09-30	1.2639	+4.5%	ratio	10-Q	2019-11-05
Quarterly	2019-12-31	1.2369	-2.1%	ratio	10-Q	2020-11-05
Quarterly	2020-03-31	1.1146	-9.9%	ratio	10-Q	2020-05-06
Quarterly	2020-06-30	1.3231	+18.7%	ratio	10-Q	2020-08-05
Quarterly	2020-09-30	1.3025	-1.6%	ratio	10-Q	2020-11-05
Quarterly	2020-12-31	1.0160	-22.0%	ratio	10-Q	2021-11-05
Quarterly	2021-03-31	1.0208	+0.5%	ratio	10-Q	2021-05-05
Quarterly	2021-06-30	1.3085	+28.2%	ratio	10-Q	2021-08-09
Quarterly	2021-09-30	1.3089	+0.0%	ratio	10-Q	2021-11-05
Quarterly	2021-12-31	1.2678	-3.1%	ratio	10-Q	2022-11-03
Quarterly	2022-03-31	1.3974	+10.2%	ratio	10-Q	2022-05-05
Quarterly	2022-06-30	1.3862	-0.8%	ratio	10-Q	2022-08-05
Quarterly	2022-09-30	1.4593	+5.3%	ratio	10-Q	2022-11-03
Quarterly	2022-12-31	1.4737	+1.0%	ratio	10-Q	2023-11-03
Quarterly	2023-03-31	1.4440	-2.0%	ratio	10-Q	2023-05-05
Quarterly	2023-06-30	1.2814	-11.3%	ratio	10-Q	2023-08-07
Quarterly	2023-09-30	1.3836	+8.0%	ratio	10-Q	2023-11-03
Quarterly	2023-12-31	1.2520	-9.5%	ratio	10-Q	2024-11-06
Quarterly	2024-03-31	1.2528	+0.1%	ratio	10-Q	2024-05-03
Quarterly	2024-06-30	1.4660	+17.0%	ratio	10-Q	2024-08-05
Quarterly	2024-09-30	1.3642	-6.9%	ratio	10-Q	2024-11-06
Quarterly	2024-12-31	1.3646	+0.0%	ratio	10-Q	2025-11-05
Quarterly	2025-03-31	1.4103	+3.3%	ratio	10-Q	2025-05-02
Quarterly	2025-06-30	1.4236	+0.9%	ratio	10-Q	2025-08-05
Quarterly	2025-09-30	1.6612	+16.7%	ratio	10-Q	2025-11-05
Annual	2016-12-31	1.7795	—	ratio	10-K	2018-02-27
Annual	2017-12-31	1.3305	-25.2%	ratio	10-K	2019-02-27
Annual	2018-12-31	1.1652	-12.4%	ratio	10-K	2020-02-26
Annual	2019-12-31	1.2369	+6.1%	ratio	10-K	2021-02-25
Annual	2020-12-31	1.0160	-17.9%	ratio	10-K	2022-02-25
Annual	2021-12-31	1.2678	+24.8%	ratio	10-K	2023-02-24
Annual	2022-12-31	1.4737	+16.2%	ratio	10-K	2024-02-26
Annual	2023-12-31	1.2520	-15.0%	ratio	10-K	2025-02-25
Annual	2024-12-31	1.3646	+9.0%	ratio	10-K	2026-02-24
Annual	2025-12-31	1.5362	+12.6%	ratio	10-K	2026-02-24

Net Margin

Profitability Q: 26 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-06-30	0.1965	—	ratio	10-Q	2018-08-07
Quarterly	2017-09-30	-0.0049	-102.5%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.0738	+1594.6%	ratio	10-Q	2019-05-08
Quarterly	2018-06-30	0.1640	+122.1%	ratio	10-Q	2019-08-06
Quarterly	2018-09-30	0.1814	+10.6%	ratio	10-Q	2019-11-05
Quarterly	2019-03-31	0.2646	+45.9%	ratio	10-Q	2020-05-06
Quarterly	2019-06-30	0.2248	-15.0%	ratio	10-Q	2020-08-05
Quarterly	2019-09-30	0.1538	-31.6%	ratio	10-Q	2020-11-05
Quarterly	2020-03-31	0.2670	+73.6%	ratio	10-Q	2021-05-05
Quarterly	2020-06-30	0.3210	+20.2%	ratio	10-Q	2021-08-09
Quarterly	2020-09-30	0.2691	-16.2%	ratio	10-Q	2021-11-05
Quarterly	2021-03-31	0.2991	+11.2%	ratio	10-Q	2022-05-05
Quarterly	2021-06-30	0.1355	-54.7%	ratio	10-Q	2022-08-05
Quarterly	2021-09-30	0.3472	+156.2%	ratio	10-Q	2022-11-03
Quarterly	2022-03-31	0.2709	-22.0%	ratio	10-Q	2023-05-05
Quarterly	2022-06-30	0.2706	-0.1%	ratio	10-Q	2023-08-07
Quarterly	2022-09-30	0.2175	-19.6%	ratio	10-Q	2023-11-03
Quarterly	2023-03-31	0.1950	-10.3%	ratio	10-Q	2024-05-03
Quarterly	2023-06-30	-0.3972	-303.7%	ratio	10-Q	2024-08-05
Quarterly	2023-09-30	0.2976	+174.9%	ratio	10-Q	2024-11-06
Quarterly	2024-03-31	0.3022	+1.5%	ratio	10-Q	2025-05-02
Quarterly	2024-06-30	0.3389	+12.2%	ratio	10-Q	2025-08-05
Quarterly	2024-09-30	0.1898	-44.0%	ratio	10-Q	2025-11-05
Quarterly	2025-03-31	0.3275	+72.6%	ratio	10-Q	2025-05-02
Quarterly	2025-06-30	0.2801	-14.4%	ratio	10-Q	2025-08-05
Quarterly	2025-09-30	0.3350	+19.6%	ratio	10-Q	2025-11-05
Annual	2016-12-31	0.0990	—	ratio	10-K	2019-02-27
Annual	2017-12-31	0.0603	-39.1%	ratio	10-K	2020-02-26
Annual	2018-12-31	0.1464	+143.0%	ratio	10-K	2021-02-25
Annual	2019-12-31	0.2516	+71.8%	ratio	10-K	2022-02-25
Annual	2020-12-31	0.1702	-32.3%	ratio	10-K	2023-02-24
Annual	2021-12-31	0.2679	+57.4%	ratio	10-K	2024-02-26
Annual	2022-12-31	0.2450	-8.5%	ratio	10-K	2025-02-25
Annual	2023-12-31	0.0063	-97.4%	ratio	10-K	2026-02-24
Annual	2024-12-31	0.2670	+4157.5%	ratio	10-K	2026-02-24
Annual	2025-12-31	0.2809	+5.2%	ratio	10-K	2026-02-24

Quick Ratio

Liquidity Q: 39 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.5531	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	0.4430	-19.9%	ratio	10-Q	2017-08-08
Quarterly	2016-09-30	0.5083	+14.8%	ratio	10-Q	2017-11-07
Quarterly	2016-12-31	0.3787	-25.5%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	0.5906	+56.0%	ratio	10-Q	2017-05-09
Quarterly	2017-06-30	0.4151	-29.7%	ratio	10-Q	2017-08-08
Quarterly	2017-09-30	0.4059	-2.2%	ratio	10-Q	2017-11-07
Quarterly	2017-12-31	0.3273	-19.4%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.2643	-19.2%	ratio	10-Q	2018-05-08
Quarterly	2018-06-30	0.2929	+10.8%	ratio	10-Q	2018-08-07
Quarterly	2018-09-30	0.4211	+43.8%	ratio	10-Q	2018-11-06
Quarterly	2018-12-31	0.3587	-14.8%	ratio	10-Q	2019-11-05
Quarterly	2019-03-31	0.4355	+21.4%	ratio	10-Q	2019-05-08
Quarterly	2019-06-30	0.3315	-23.9%	ratio	10-Q	2019-08-06
Quarterly	2019-09-30	0.3804	+14.7%	ratio	10-Q	2019-11-05
Quarterly	2019-12-31	0.4355	+14.5%	ratio	10-Q	2020-11-05
Quarterly	2020-03-31	0.3162	-27.4%	ratio	10-Q	2020-05-06
Quarterly	2020-06-30	0.5006	+58.3%	ratio	10-Q	2020-08-05
Quarterly	2020-09-30	0.3605	-28.0%	ratio	10-Q	2020-11-05
Quarterly	2020-12-31	0.2946	-18.3%	ratio	10-Q	2021-11-05
Quarterly	2021-03-31	0.2648	-10.1%	ratio	10-Q	2021-05-05
Quarterly	2021-06-30	0.3914	+47.8%	ratio	10-Q	2021-08-09
Quarterly	2021-09-30	0.4221	+7.8%	ratio	10-Q	2021-11-05
Quarterly	2021-12-31	0.3391	-19.7%	ratio	10-Q	2022-11-03
Quarterly	2022-03-31	0.3834	+13.1%	ratio	10-Q	2022-05-05
Quarterly	2022-06-30	0.4176	+8.9%	ratio	10-Q	2022-08-05
Quarterly	2022-09-30	0.4846	+16.0%	ratio	10-Q	2022-11-03
Quarterly	2022-12-31	0.5237	+8.1%	ratio	10-Q	2023-11-03
Quarterly	2023-03-31	0.4197	-19.9%	ratio	10-Q	2023-05-05
Quarterly	2023-06-30	0.2419	-42.3%	ratio	10-Q	2023-08-07
Quarterly	2023-09-30	0.3726	+54.0%	ratio	10-Q	2023-11-03
Quarterly	2023-12-31	0.2662	-28.5%	ratio	10-Q	2024-11-06
Quarterly	2024-03-31	0.2223	-16.5%	ratio	10-Q	2024-05-03
Quarterly	2024-06-30	0.4338	+95.1%	ratio	10-Q	2024-08-05
Quarterly	2024-09-30	0.4932	+13.7%	ratio	10-Q	2024-11-06
Quarterly	2024-12-31	0.4659	-5.5%	ratio	10-Q	2025-11-05
Quarterly	2025-03-31	0.3428	-26.4%	ratio	10-Q	2025-05-02
Quarterly	2025-06-30	0.3075	-10.3%	ratio	10-Q	2025-08-05
Quarterly	2025-09-30	0.6347	+106.4%	ratio	10-Q	2025-11-05
Annual	2016-12-31	0.3787	—	ratio	10-K	2018-02-27
Annual	2017-12-31	0.3273	-13.6%	ratio	10-K	2019-02-27
Annual	2018-12-31	0.3587	+9.6%	ratio	10-K	2020-02-26
Annual	2019-12-31	0.4355	+21.4%	ratio	10-K	2021-02-25
Annual	2020-12-31	0.2946	-32.4%	ratio	10-K	2022-02-25
Annual	2021-12-31	0.3391	+15.1%	ratio	10-K	2023-02-24
Annual	2022-12-31	0.5237	+54.4%	ratio	10-K	2024-02-26
Annual	2023-12-31	0.2662	-49.2%	ratio	10-K	2025-02-25
Annual	2024-12-31	0.4659	+75.0%	ratio	10-K	2026-02-24
Annual	2025-12-31	0.5142	+10.4%	ratio	10-K	2026-02-24

ROA

Profitability Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0114	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	0.0125	+9.5%	ratio	10-Q	2017-08-08
Quarterly	2016-09-30	0.0223	+77.6%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	0.0161	-27.6%	ratio	10-Q	2018-05-08
Quarterly	2017-06-30	0.0210	+30.5%	ratio	10-Q	2018-08-07
Quarterly	2017-09-30	-0.0006	-102.6%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.0086	+1648.1%	ratio	10-Q	2019-05-08
Quarterly	2018-06-30	0.0202	+134.3%	ratio	10-Q	2019-08-06
Quarterly	2018-09-30	0.0230	+14.0%	ratio	10-Q	2019-11-05
Quarterly	2019-03-31	0.0348	+51.1%	ratio	10-Q	2020-05-06
Quarterly	2019-06-30	0.0315	-9.4%	ratio	10-Q	2020-08-05
Quarterly	2019-09-30	0.0229	-27.3%	ratio	10-Q	2020-11-05
Quarterly	2020-03-31	0.0379	+65.7%	ratio	10-Q	2021-05-05
Quarterly	2020-06-30	0.0331	-12.6%	ratio	10-Q	2021-08-09
Quarterly	2020-09-30	0.0328	-1.1%	ratio	10-Q	2021-11-05
Quarterly	2021-03-31	0.0350	+6.8%	ratio	10-Q	2022-05-05
Quarterly	2021-06-30	0.0170	-51.3%	ratio	10-Q	2022-08-05
Quarterly	2021-09-30	0.0488	+186.7%	ratio	10-Q	2022-11-03
Quarterly	2022-03-31	0.0404	-17.3%	ratio	10-Q	2023-05-05
Quarterly	2022-06-30	0.0369	-8.7%	ratio	10-Q	2023-08-07
Quarterly	2022-09-30	0.0304	-17.6%	ratio	10-Q	2023-11-03
Quarterly	2023-03-31	0.0262	-13.7%	ratio	10-Q	2024-05-03
Quarterly	2023-06-30	-0.0572	-318.1%	ratio	10-Q	2024-08-05
Quarterly	2023-09-30	0.0445	+177.9%	ratio	10-Q	2024-11-06
Quarterly	2024-03-31	0.0450	+1.2%	ratio	10-Q	2025-05-02
Quarterly	2024-06-30	0.0485	+7.7%	ratio	10-Q	2025-08-05
Quarterly	2024-09-30	0.0269	-44.5%	ratio	10-Q	2025-11-05
Quarterly	2025-03-31	0.0442	+64.2%	ratio	10-Q	2025-05-02
Quarterly	2025-06-30	0.0377	-14.7%	ratio	10-Q	2025-08-05
Quarterly	2025-09-30	0.0447	+18.6%	ratio	10-Q	2025-11-05
Annual	2016-12-31	0.0413	—	ratio	10-K	2019-02-27
Annual	2017-12-31	0.0275	-33.4%	ratio	10-K	2020-02-26
Annual	2018-12-31	0.0749	+172.3%	ratio	10-K	2021-02-25
Annual	2019-12-31	0.1166	+55.6%	ratio	10-K	2022-02-25
Annual	2020-12-31	0.0772	-33.8%	ratio	10-K	2023-02-24
Annual	2021-12-31	0.1235	+60.0%	ratio	10-K	2024-02-26
Annual	2022-12-31	0.1331	+7.8%	ratio	10-K	2025-02-25
Annual	2023-12-31	0.0035	-97.3%	ratio	10-K	2026-02-24
Annual	2024-12-31	0.1463	+4039.8%	ratio	10-K	2026-02-24
Annual	2025-12-31	0.1334	-8.8%	ratio	10-K	2026-02-24

ROE

Profitability Q: 30 | A: 10

Quarterly

Annual

Show Data Rows

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0257	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	0.0278	+8.1%	ratio	10-Q	2017-08-08
Quarterly	2016-09-30	0.0498	+78.9%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	0.0388	-22.0%	ratio	10-Q	2018-05-08
Quarterly	2017-06-30	0.0491	+26.6%	ratio	10-Q	2018-08-07
Quarterly	2017-09-30	-0.0013	-102.7%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.0219	+1750.0%	ratio	10-Q	2019-05-08
Quarterly	2018-06-30	0.0524	+139.6%	ratio	10-Q	2019-08-06
Quarterly	2018-09-30	0.0600	+14.5%	ratio	10-Q	2019-11-05
Quarterly	2019-03-31	0.1034	+72.5%	ratio	10-Q	2020-05-06
Quarterly	2019-06-30	0.0953	-7.8%	ratio	10-Q	2020-08-05
Quarterly	2019-09-30	0.0708	-25.7%	ratio	10-Q	2020-11-05
Quarterly	2020-03-31	0.1224	+72.8%	ratio	10-Q	2021-05-05
Quarterly	2020-06-30	0.1082	-11.6%	ratio	10-Q	2021-08-09
Quarterly	2020-09-30	0.1005	-7.1%	ratio	10-Q	2021-11-05
Quarterly	2021-03-31	0.1176	+17.0%	ratio	10-Q	2022-05-05
Quarterly	2021-06-30	0.0463	-60.6%	ratio	10-Q	2022-08-05
Quarterly	2021-09-30	0.1273	+175.2%	ratio	10-Q	2022-11-03
Quarterly	2022-03-31	0.1052	-17.4%	ratio	10-Q	2023-05-05
Quarterly	2022-06-30	0.0912	-13.3%	ratio	10-Q	2023-08-07
Quarterly	2022-09-30	0.0731	-19.9%	ratio	10-Q	2023-11-03
Quarterly	2023-03-31	0.0602	-17.6%	ratio	10-Q	2024-05-03
Quarterly	2023-06-30	-0.1541	-355.9%	ratio	10-Q	2024-08-05
Quarterly	2023-09-30	0.1150	+174.6%	ratio	10-Q	2024-11-06
Quarterly	2024-03-31	0.1179	+2.5%	ratio	10-Q	2025-05-02
Quarterly	2024-06-30	0.1251	+6.1%	ratio	10-Q	2025-08-05
Quarterly	2024-09-30	0.0709	-43.3%	ratio	10-Q	2025-11-05
Quarterly	2025-03-31	0.1051	+48.1%	ratio	10-Q	2025-05-02
Quarterly	2025-06-30	0.0903	-14.1%	ratio	10-Q	2025-08-05
Quarterly	2025-09-30	0.1115	+23.5%	ratio	10-Q	2025-11-05
Annual	2016-12-31	0.0978	—	ratio	10-K	2019-02-27
Annual	2017-12-31	0.0699	-28.5%	ratio	10-K	2020-02-26
Annual	2018-12-31	0.2304	+229.4%	ratio	10-K	2021-02-25
Annual	2019-12-31	0.3786	+64.3%	ratio	10-K	2022-02-25
Annual	2020-12-31	0.2782	-26.5%	ratio	10-K	2023-02-24
Annual	2021-12-31	0.3411	+22.6%	ratio	10-K	2024-02-26
Annual	2022-12-31	0.3154	-7.5%	ratio	10-K	2025-02-25
Annual	2023-12-31	0.0100	-96.8%	ratio	10-K	2026-02-24
Annual	2024-12-31	0.3695	+3588.3%	ratio	10-K	2026-02-24
Annual	2025-12-31	0.3468	-6.1%	ratio	10-K	2026-02-24

8-K Material Event Details

43 filings · 86 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

490 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-31	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	68	$120.29	$8,125	19,238
2026-02-12	Guindo Chirfi	Chief Marketing Officer	Open-market sell S	Common Stock	10,000	$121.46	$1,214,562	60,615
2026-02-10	Li Dean Y	Executive VP & President, MRL	Open-market sell S	Common Stock	10,235	$117.52	$1,202,844	92,035
2026-02-09	Guindo Chirfi	Chief Marketing Officer	Open-market sell S	Common Stock	10,000	$118.41	$1,184,101	70,615
2026-02-06	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	5,000	$0.00	$0	4,600
2026-02-06	Williams David Michael	EVP,Chief Info&Digital Officer	Open-market sell S	Common Stock	5,000	$121.91	$609,525	30,838
2026-02-06	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M	Common Stock	5,000	$77.62	$388,100	35,838
2026-02-05	Guindo Chirfi	Chief Marketing Officer	Open-market sell S	Common Stock	20,000	$121.88	$2,437,676	80,615
2026-02-04	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Stock Option (Right to Buy)	4,000	$0.00	$0	8,130
2026-02-04	Smart Dalton E. III	SVP Fin. - Global Controller	Open-market sell S	Common Stock	2,400	$119.67	$287,220	8,205
2026-02-04	Smart Dalton E. III	SVP Fin. - Global Controller	Open-market sell S	Common Stock	4,000	$119.67	$478,700	10,605
2026-02-04	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	4,000	$62.07	$248,280	14,605
2026-01-26	Zachary Jennifer	EVP, General Counsel	Equity grant / award A	Common Stock	11,583	$107.40	$1,244,014	68,916
2025-12-31	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	77	$105.26	$8,125	19,026
2025-11-10	Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Open-market sell S	Common Stock	7,085	$87.00	$616,395	0
2025-11-03	Williams David Michael	EVP,Chief Info&Digital Officer	Open-market sell S	Common Stock	8,614	$83.59	$720,040	24,578
2025-09-30	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	97	$83.93	$8,125	18,776
2025-08-04	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M · derivative	Restricted Stock Unit	17,119	$0.00	$0	0
2025-08-04	Williams David Michael	EVP,Chief Info&Digital Officer	Other disposed transaction F	Common Stock	8,432	$79.29	$668,573	33,013
2025-08-04	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M	Common Stock	17,119	$79.29	$1,357,366	41,445
2025-06-30	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	103	$79.16	$8,125	18,496
2025-05-30	Warden Kathy J	Dir	Equity grant / award A · derivative	Phantom Stock	2,863	$76.84	$220,000	15,504
2025-05-03	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	1,532	$0.00	$0	0
2025-05-03	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	518	$0.00	$0	0
2025-05-03	Smart Dalton E. III	SVP Fin. - Global Controller	Other disposed transaction F	Common Stock	588	$83.18	$48,910	9,539
2025-05-03	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	1,532	$83.18	$127,432	10,127
2025-05-03	Smart Dalton E. III	SVP Fin. - Global Controller	Other disposed transaction F	Common Stock	256	$83.18	$21,294	8,595
2025-05-03	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	518	$83.18	$43,087	8,851
2025-05-02	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	381	$0.00	$0	383
2025-05-02	Smart Dalton E. III	SVP Fin. - Global Controller	Other disposed transaction F	Common Stock	131	$83.26	$10,907	8,333
2025-05-02	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	381	$83.26	$31,722	8,464
2025-04-30	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	464	$0.00	$0	929
2025-04-30	Smart Dalton E. III	SVP Fin. - Global Controller	Other disposed transaction F	Common Stock	159	$84.71	$13,469	8,083
2025-04-30	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	464	$84.71	$39,305	8,242
2025-04-29	Smart Dalton E. III	SVP Fin. - Global Controller	Equity grant / award A · derivative	Stock Option (Right to Buy)	6,448	$0.00	$0	6,448
2025-04-29	Smart Dalton E. III	SVP Fin. - Global Controller	Equity grant / award A · derivative	Restricted Stock Unit	2,833	$0.00	$0	2,833
2025-04-25	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Stock Option (Right to Buy)	5,000	$0.00	$0	0
2025-04-25	Smart Dalton E. III	SVP Fin. - Global Controller	Open-market sell S	Common Stock	4,262	$82.76	$352,723	7,778
2025-04-25	Smart Dalton E. III	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	5,000	$58.08	$290,400	12,040
2025-03-31	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	91	$89.76	$8,125	15,378
2025-02-19	Oosthuizen Johannes Jacobus	President, U.S. Market	Open-market sell S	Common Stock	8,500	$84.09	$714,745	30,705
2025-02-13	Williams David Michael	EVP,Chief Info&Digital Officer	Open-market sell S	Common Stock	6,000	$85.34	$512,057	24,123
2025-02-08	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M · derivative	Restricted Stock Unit	13,002	$0.00	$0	0
2025-02-08	Oosthuizen Johannes Jacobus	President, U.S. Market	Other disposed transaction F	Common Stock	6,404	$87.28	$558,941	39,205
2025-02-08	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M	Common Stock	13,002	$87.28	$1,134,815	45,609
2025-02-06	THULIN INGE G	Dir	Open-market buy P	Common Stock	2,833	$88.25	$250,000	2,933
2025-02-05	BAKER DOUGLAS M JR	Dir	Open-market buy P	Common Stock	15,000	$88.50	$1,327,500	16,000
2025-01-27	Zachary Jennifer	EVP, General Counsel	Equity grant / award A	Common Stock	25,423	$97.94	$2,489,929	55,286
2025-01-01	Karsanbhai Surendralal Lanca	Dir	Equity grant / award A · derivative	Phantom Stock	553	$99.48	$55,000	553
2024-12-31	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	82	$99.48	$8,125	15,165
2024-09-30	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	72	$113.56	$8,125	14,977
2024-08-05	Guindo Chirfi	Chief Marketing Officer	Exercise / conversion M · derivative	Restricted Stock Unit	36,901	$0.00	$0	36,903
2024-08-05	Guindo Chirfi	Chief Marketing Officer	Other disposed transaction F	Common Stock	17,412	$115.20	$2,005,862	40,370
2024-08-05	Guindo Chirfi	Chief Marketing Officer	Exercise / conversion M	Common Stock	36,901	$115.20	$4,250,995	57,782
2024-06-28	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	66	$123.80	$8,125	14,816
2024-05-31	RUSSO PATRICIA F	Dir	Equity grant / award A · derivative	Phantom Stock	1,752	$125.54	$220,000	53,952
2024-05-04	Smart Dalton	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	612	$0.00	$0	0
2024-05-04	Smart Dalton	SVP Fin. - Global Controller	Other disposed transaction F	Common Stock	302	$127.51	$38,508	4,428
2024-05-04	Smart Dalton	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	612	$127.51	$78,036	4,730
2024-05-04	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M · derivative	Restricted Stock Unit	27,126	$0.00	$0	0
2024-05-04	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Other disposed transaction F	Common Stock	13,360	$127.51	$1,703,534	150,360
2024-05-04	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M	Common Stock	27,126	$127.51	$3,458,836	163,720
2024-05-03	Smart Dalton	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	1,530	$0.00	$0	1,532
2024-05-03	Smart Dalton	SVP Fin. - Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	516	$0.00	$0	518
2024-05-03	Smart Dalton	SVP Fin. - Global Controller	Other disposed transaction F	Common Stock	590	$128.26	$75,673	4,118
2024-05-03	Smart Dalton	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	1,530	$128.26	$196,238	4,708
2024-05-03	Smart Dalton	SVP Fin. - Global Controller	Other disposed transaction F	Common Stock	255	$128.26	$32,706	3,178
2024-05-03	Smart Dalton	SVP Fin. - Global Controller	Exercise / conversion M	Common Stock	516	$128.26	$66,182	3,433
2024-05-02	Romanelli Joseph	President, Human Health Int?l	Exercise / conversion M · derivative	Restricted Stock Unit	2,262	$0.00	$0	4,524
2024-05-02	Romanelli Joseph	President, Human Health Int?l	Other disposed transaction F	Common Stock	1,115	$128.80	$143,612	20,716
2024-05-02	Romanelli Joseph	President, Human Health Int?l	Exercise / conversion M	Common Stock	2,262	$128.80	$291,346	21,831
2024-04-30	Romanelli Joseph	President, Human Health Int?l	Equity grant / award A · derivative	Stock Option (Right to Buy)	23,438	$0.00	$0	23,438
2024-04-30	Romanelli Joseph	President, Human Health Int?l	Equity grant / award A · derivative	Restricted Stock Unit	6,191	$0.00	$0	6,191
2024-03-28	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	227	$131.95	$30,000	124,753
2024-03-11	Merck & Co., Inc.	—	Open-market buy P	Common Stock, par value $0.0001	21,397,205	$23.00	$492,135,715	1,000
2024-02-14	Davis Robert M	Chairman, CEO & President	Exercise / conversion M · derivative	Stock Option (Right to Buy)	85,021	$0.00	$0	96,760
2024-02-14	Davis Robert M	Chairman, CEO & President	Open-market sell S	Common Stock	85,021	$125.40	$10,661,574	348,327
2024-02-14	Davis Robert M	Chairman, CEO & President	Exercise / conversion M	Common Stock	85,021	$73.73	$6,268,598	433,348
2024-02-14	Litchfield Caroline	EVP & CFO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	38,291	$0.00	$0	0
2024-02-14	Litchfield Caroline	EVP & CFO	Open-market sell S	Common Stock	38,291	$125.50	$4,805,520	50,908
2024-02-14	Litchfield Caroline	EVP & CFO	Exercise / conversion M	Common Stock	38,291	$58.08	$2,223,941	89,199
2024-02-13	Davis Robert M	Chairman, CEO & President	Exercise / conversion M · derivative	Stock Option (Right to Buy)	108,491	$0.00	$0	181,781
2024-02-13	Davis Robert M	Chairman, CEO & President	Exercise / conversion M · derivative	Stock Option (Right to Buy)	41,509	$0.00	$0	83,020
2024-02-13	Davis Robert M	Chairman, CEO & President	Open-market sell S	Common Stock	25,324	$126.37	$3,200,277	348,327
2024-02-13	Davis Robert M	Chairman, CEO & President	Open-market sell S	Common Stock	124,676	$125.74	$15,677,147	373,651
2024-02-13	Davis Robert M	Chairman, CEO & President	Exercise / conversion M	Common Stock	108,491	$73.73	$7,999,041	498,327
2024-02-13	Davis Robert M	Chairman, CEO & President	Exercise / conversion M	Common Stock	41,509	$75.36	$3,128,118	389,836
2024-02-09	Li Dean Y	Executive VP & President, MRL	Exercise / conversion M · derivative	Stock Option (Right to Buy)	14,702	$0.00	$0	0
2024-02-09	Li Dean Y	Executive VP & President, MRL	Open-market sell S	Common Stock	14,702	$125.50	$1,845,083	46,242
2024-02-09	Li Dean Y	Executive VP & President, MRL	Exercise / conversion M	Common Stock	14,702	$62.07	$912,553	60,944
2024-02-07	Williams David Michael	EVP,Chief Info&Digital Officer	Open-market sell S	Common Stock	1,451	$127.57	$185,108	19,812
2024-02-02	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,119	$0.00	$0	14,240
2024-02-02	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,045	$0.00	$0	7,049
2024-02-02	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M · derivative	Stock Option (Right to Buy)	6,773	$0.00	$0	0
2024-02-02	Oosthuizen Johannes Jacobus	President, U.S. Market	Open-market sell S	Common Stock	18,959	$127.17	$2,411,111	23,327
2024-02-02	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M	Common Stock	7,119	$87.10	$620,065	42,286
2024-02-02	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M	Common Stock	7,045	$73.73	$519,428	35,167
2024-02-02	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M	Common Stock	6,773	$75.36	$510,413	28,122
2024-01-22	Oosthuizen Johannes Jacobus	President, U.S. Market	Equity grant / award A	Common Stock	3,133	$119.43	$374,174	21,349
2023-12-29	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	275	$109.02	$30,000	123,716
2023-11-09	Oosthuizen Johannes Jacobus	President, U.S. Market	Open-market sell S	Common Stock	2,081	$102.38	$213,061	18,191
2023-11-08	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Open-market sell S	Common Stock	43,823	$105.03	$4,602,668	111,764
2023-10-31	Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Equity grant / award A · derivative	Restricted Stock Unit	11,685	$0.00	$0	11,685
2023-10-30	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M · derivative	Restricted Stock Unit	915	$0.00	$0	0
2023-10-30	Oosthuizen Johannes Jacobus	President, U.S. Market	Other disposed transaction F	Common Stock	451	$102.82	$46,372	20,272
2023-10-30	Oosthuizen Johannes Jacobus	President, U.S. Market	Exercise / conversion M	Common Stock	915	$102.82	$94,080	20,723
2023-09-29	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	291	$102.95	$30,000	122,581
2023-08-14	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	4,250	$109.01	$463,292	22,935
2023-08-03	Guindo Chirfi	Chief Marketing Officer	Exercise / conversion M · derivative	Restricted Stock Unit	36,901	$0.00	$0	73,804
2023-08-03	Guindo Chirfi	Chief Marketing Officer	Other disposed transaction F	Common Stock	17,989	$105.70	$1,901,437	20,353
2023-08-03	Guindo Chirfi	Chief Marketing Officer	Exercise / conversion M	Common Stock	36,901	$105.70	$3,900,436	38,342
2023-08-02	Romanelli Joseph	President, Human Health Int?l	Open-market sell S	Common Stock	59	$107.37	$6,335	0
2023-08-02	Romanelli Joseph	President, Human Health Int?l	Open-market sell S	Common Stock	30	$107.37	$3,221	20,569
2023-06-30	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	260	$115.39	$30,000	121,485
2023-05-26	LAVIZZO-MOUREY RISA J	Dir	Equity grant / award A · derivative	Phantom Stock	1,981	$111.07	$220,000	10,100
2023-05-04	Zachary Jennifer	EVP, General Counsel	Open-market sell S	Common Stock	19,141	$117.59	$2,250,834	35,128
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,000	$0.00	$0	44,151
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	12,000	$0.00	$0	32,151
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	13,000	$0.00	$0	39,366
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	13,400	$119.01	$1,594,734	31,685
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	12,000	$119.01	$1,428,089	33,085
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	15,000	$119.01	$1,785,122	45,085
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	13,000	$119.01	$1,547,112	60,085
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M	Common Stock	12,000	$75.36	$904,320	45,085
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M	Common Stock	15,000	$75.36	$1,130,400	61,085
2023-05-03	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M	Common Stock	13,000	$77.62	$1,009,060	46,085
2023-05-02	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	6,035	$0.00	$0	0
2023-05-02	Williams David Michael	EVP,Chief Info&Digital Officer	Open-market sell S	Common Stock	7,509	$116.82	$877,222	11,059
2023-05-02	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M	Common Stock	6,035	$56.04	$338,201	18,568
2023-05-02	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Equity grant / award A · derivative	Restricted Stock Unit	1,781	$0.00	$0	1,781
2023-05-02	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Equity grant / award A · derivative	Stock Option (Right to Buy)	9,682	$0.00	$0	9,682
2023-05-01	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M · derivative	Stock Option (Right to Buy)	75,436	$0.00	$0	0
2023-05-01	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Open-market sell S	Common Stock	75,436	$116.03	$8,752,749	154,493
2023-05-01	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M	Common Stock	75,436	$56.04	$4,227,433	229,929
2023-05-01	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M · derivative	Restricted Stock Unit	577	$0.00	$0	0
2023-05-01	Williams David Michael	EVP,Chief Info&Digital Officer	Other disposed transaction F	Common Stock	198	$115.47	$22,863	12,533
2023-05-01	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M	Common Stock	577	$115.47	$66,626	12,731
2023-04-28	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M · derivative	Stock Option (Right to Buy)	66,163	$0.00	$0	0
2023-04-28	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Open-market sell S	Common Stock	66,163	$115.00	$7,608,844	154,493
2023-04-28	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M	Common Stock	66,163	$62.07	$4,106,737	220,656
2023-04-26	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	3	$113.68	$341	20,599
2023-04-13	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (Right to Buy)	66,163	$0.00	$0	0
2023-04-13	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (Right to Buy)	67,892	$0.00	$0	0
2023-04-13	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	67,892	$115.07	$7,812,366	0
2023-04-13	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	66,163	$115.06	$7,612,702	67,892
2023-04-13	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	66,163	$62.07	$4,106,737	134,055
2023-04-13	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	67,892	$56.04	$3,804,668	67,892
2023-03-31	Coe Mary Ellen	Dir	Equity grant / award A · derivative	Phantom Stock	304	$106.39	$32,361	17,499
2023-03-24	Romanelli Joseph	President, Human Health Int?l	Open-market sell S	Common Stock	35	$104.65	$3,663	20,596
2023-03-20	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	136	$105.47	$14,344	20,631
2023-02-21	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	11	$109.20	$1,201	20,495
2023-02-15	Romanelli Joseph	President, Human Health Int?l	Open-market sell S	Common Stock	5,000	$108.22	$541,100	20,284
2023-02-13	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	1,815	$109.10	$198,017	33,085
2023-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,205	$0.00	$0	0
2023-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Other disposed transaction F	Common Stock	413	$106.72	$44,075	12,092
2023-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M	Common Stock	1,205	$106.72	$128,598	12,505
2023-02-09	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	5,000	$107.00	$535,006	34,900
2023-02-06	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	4,436	$104.25	$462,473	39,900
2023-02-03	Zachary Jennifer	EVP, General Counsel	Exercise / conversion M · derivative	Stock Option (Right to Buy)	75,436	$0.00	$0	0
2023-02-03	Zachary Jennifer	EVP, General Counsel	Open-market sell S	Common Stock	75,436	$103.17	$7,782,762	53,920
2023-02-03	Zachary Jennifer	EVP, General Counsel	Exercise / conversion M	Common Stock	75,436	$56.04	$4,227,433	129,356
2023-01-23	Oosthuizen Johannes Jacobus	President, U.S. Market	Equity grant / award A	Common Stock	2,091	$109.88	$229,759	18,822
2023-01-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (Right to Buy)	83,994	$0.00	$0	0
2023-01-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	1,702	$114.46	$194,813	29,500
2023-01-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	38,216	$113.78	$4,348,033	31,202
2023-01-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	3,940	$112.78	$444,362	69,418
2023-01-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	4,538	$111.73	$507,048	73,358
2023-01-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	35,598	$110.61	$3,937,659	77,896
2023-01-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	83,994	$53.06	$4,456,722	113,494
2022-12-30	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	270	$110.95	$30,000	117,421
2022-12-19	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	7	$109.04	$763	20,484
2022-12-13	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	56	$110.96	$6,214	20,477
2022-12-06	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	30	$109.39	$3,282	20,421
2022-12-05	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	107	$109.54	$11,721	20,391
2022-12-02	Romanelli Joseph	President, Human Health Int?l	Open-market buy P	Common Stock	59	$109.67	$6,471	59
2022-11-10	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,000	$0.00	$0	824
2022-11-10	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	15,000	$101.42	$1,521,278	32,144
2022-11-10	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M	Common Stock	15,000	$0.00	$0	47,144
2022-11-09	Oosthuizen Johannes Jacobus	President, U.S. Market	Open-market sell S	Common Stock	1,795	$103.21	$185,262	16,731
2022-11-08	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	20,000	$0.00	$0	15,824
2022-11-08	MIZELL STEVEN	EVP, Chief HR Officer	Open-market sell S	Common Stock	20,000	$101.00	$2,020,000	32,144
2022-11-08	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M	Common Stock	20,000	$0.00	$0	52,144
2022-11-07	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M · derivative	Stock Option (Right to Buy)	235,769	$0.00	$0	0
2022-11-07	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	84,721	$100.07	$8,477,717	700,653
2022-11-07	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	126,134	$99.42	$12,540,835	785,374
2022-11-07	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	24,914	$98.45	$2,452,880	911,508
2022-11-07	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M	Common Stock	235,769	$0.00	$0	936,422
2022-11-04	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M · derivative	Stock Option (Right to Buy)	235,000	$0.00	$0	235,769
2022-11-04	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	34,810	$99.08	$3,448,989	700,653
2022-11-04	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	200,190	$98.53	$19,725,241	735,463
2022-11-04	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M	Common Stock	235,000	$0.00	$0	935,653
2022-11-03	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M · derivative	Stock Option (Right to Buy)	235,000	$0.00	$0	470,769
2022-11-03	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	20,383	$99.09	$2,019,804	700,653
2022-11-03	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	214,617	$98.68	$21,178,084	721,036
2022-11-03	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M	Common Stock	235,000	$0.00	$0	935,653
2022-11-02	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M · derivative	Stock Option (Right to Buy)	134,172	$0.00	$0	705,769
2022-11-02	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M · derivative	Stock Option (Right to Buy)	165,828	$0.00	$0	0
2022-11-02	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	94,339	$100.40	$9,471,739	700,653
2022-11-02	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	205,661	$99.68	$20,500,103	794,992
2022-11-02	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M	Common Stock	134,172	$0.00	$0	1,000,653
2022-11-02	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M	Common Stock	165,828	$0.00	$0	866,481
2022-11-01	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M · derivative	Stock Option (Right to Buy)	300,000	$0.00	$0	165,828
2022-11-01	FRAZIER KENNETH C	Executive Chair	Equity grant / award G	Common Stock	1,470	$0.00	$0	700,653
2022-11-01	FRAZIER KENNETH C	Executive Chair	Equity grant / award G	Common Stock	2,450	$0.00	$0	702,123
2022-11-01	FRAZIER KENNETH C	Executive Chair	Equity grant / award G	Common Stock	1,710	$0.00	$0	704,573
2022-11-01	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	700	$101.05	$70,733	706,283
2022-11-01	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	96,981	$100.22	$9,719,843	706,983
2022-11-01	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	202,319	$99.61	$20,152,287	803,964
2022-11-01	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M	Common Stock	300,000	$0.00	$0	1,006,283
2022-10-28	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (Right to Buy)	51,055	$0.00	$0	0
2022-10-28	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (Right to Buy)	34,024	$0.00	$0	0
2022-10-28	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,213	$0.00	$0	0
2022-10-28	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	100,292	$100.10	$10,039,380	45,608
2022-10-28	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	51,055	$0.00	$0	145,900
2022-10-28	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	34,024	$0.00	$0	94,845
2022-10-28	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	15,213	$0.00	$0	60,821
2022-09-30	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	348	$86.12	$30,000	116,238
2022-08-03	FRAZIER KENNETH C	Executive Chair	Equity grant / award A · derivative	Restricted Stock Unit	28,532	$0.00	$0	28,532
2022-06-30	Coe Mary Ellen	Dir	Equity grant / award A · derivative	Phantom Stock	356	$91.17	$32,500	16,168
2022-05-27	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	2,364	$93.08	$220,000	114,707
2022-05-04	Oosthuizen Johannes Jacobus	SVP, U.S. Market	Exercise / conversion M · derivative	Restricted Stock Unit	907	$0.00	$0	1,819
2022-05-04	Oosthuizen Johannes Jacobus	SVP, U.S. Market	Other disposed transaction F	Common Stock	447	$87.10	$38,934	14,514
2022-05-04	Oosthuizen Johannes Jacobus	SVP, U.S. Market	Exercise / conversion M	Common Stock	907	$87.10	$79,000	14,961
2022-05-03	Oosthuizen Johannes Jacobus	SVP, U.S. Market	Equity grant / award A · derivative	Stock Option (Right to Buy)	21,359	$0.00	$0	21,359
2022-05-01	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Exercise / conversion M · derivative	Restricted Stock Unit	640	$0.00	$0	643
2022-05-01	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Other disposed transaction F	Common Stock	220	$88.69	$19,512	2,833
2022-05-01	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Exercise / conversion M	Common Stock	640	$88.69	$56,762	3,053
2022-03-31	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	366	$82.05	$30,000	111,461
2022-02-24	Zachary Jennifer	EVP, General Counsel	Equity grant / award A	Common Stock	18,420	$73.51	$1,354,054	53,419
2022-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,202	$0.00	$0	1,205
2022-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Other disposed transaction F	Common Stock	477	$76.53	$36,505	6,944
2022-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M	Common Stock	1,202	$76.53	$91,989	7,421
2021-12-31	Coe Mary Ellen	Dir	Equity grant / award A · derivative	Phantom Stock	424	$76.64	$32,500	12,842
2021-11-09	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M · derivative	Stock Option (Right to Buy)	663,881	$0.00	$0	0
2021-11-09	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	29,615	$83.23	$2,464,865	586,795
2021-11-09	FRAZIER KENNETH C	Executive Chair	Open-market sell S	Common Stock	634,266	$82.22	$52,146,496	616,410
2021-11-09	FRAZIER KENNETH C	Executive Chair	Exercise / conversion M	Common Stock	663,881	$0.00	$0	1,250,676
2021-11-04	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M · derivative	Stock Option (Right to Buy)	29,782	$0.00	$0	59,564
2021-11-04	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Open-market sell S	Common Stock	29,782	$90.40	$2,692,299	116,930
2021-11-04	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M	Common Stock	29,782	$0.00	$0	146,712
2021-11-03	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M · derivative	Stock Option (Right to Buy)	25,000	$0.00	$0	16,997
2021-11-03	Karachun Rita A	Sr. VP Fince-Global Controller	Open-market sell S	Common Stock	25,000	$88.45	$2,211,215	35,799
2021-11-03	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M	Common Stock	25,000	$0.00	$0	60,799
2021-11-01	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,847	$0.00	$0	19,848
2021-11-01	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,915	$0.00	$0	0
2021-11-01	Clyburn Frank	EVP & Pres ? Human Health	Open-market sell S	Common Stock	39,762	$87.87	$3,493,879	97,095
2021-11-01	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M	Common Stock	19,847	$0.00	$0	136,857
2021-11-01	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M	Common Stock	19,915	$0.00	$0	117,010
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	11,414	$0.00	$0	22,831
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,394	$0.00	$0	9,698
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	30,175	$0.00	$0	0
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	35,287	$0.00	$0	0
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Open-market sell S	Common Stock	96,270	$87.91	$8,462,682	39,162
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M	Common Stock	11,414	$0.00	$0	135,432
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M	Common Stock	19,394	$0.00	$0	124,018
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M	Common Stock	30,175	$0.00	$0	104,624
2021-11-01	Gerberding Julie L.	EVP, Chief Patient Officer	Exercise / conversion M	Common Stock	35,287	$0.00	$0	74,449
2021-10-30	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M · derivative	Restricted Stock Unit	2,358	$0.00	$0	0
2021-10-30	Clyburn Frank	EVP & Pres ? Human Health	Other disposed transaction F	Common Stock	1,162	$88.05	$102,314	97,095
2021-10-30	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M	Common Stock	2,358	$88.05	$207,622	98,257
2021-10-29	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (Right to Buy)	24,619	$0.00	$0	15,213
2021-10-29	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	24,619	$87.32	$2,149,731	93,145
2021-10-29	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	24,619	$0.00	$0	117,764
2021-09-30	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	399	$75.11	$30,000	108,900
2021-06-30	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	386	$77.77	$30,000	107,613
2021-06-02	Merck & Co., Inc.	10%	Other disposed transaction J	Common Stock	253,516,000	—	—	0
2021-05-28	RUSSO PATRICIA F	Dir	Equity grant / award A · derivative	Phantom Stock	2,635	$75.89	$200,000	42,394
2021-05-10	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,324	$0.00	$0	19,323
2021-05-10	Clyburn Frank	EVP & Pres ? Human Health	Open-market sell S	Common Stock	19,324	$78.32	$1,513,440	94,348
2021-05-10	Clyburn Frank	EVP & Pres ? Human Health	Exercise / conversion M	Common Stock	19,324	$0.00	$0	113,672
2021-05-04	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Equity grant / award A · derivative	Restricted Stock Unit	26,319	$0.00	$0	26,319
2021-05-03	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Exercise / conversion M · derivative	Restricted Stock Unit	437	$0.00	$0	439
2021-05-03	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Other disposed transaction F	Common Stock	150	$74.50	$11,175	1,918
2021-05-03	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Exercise / conversion M	Common Stock	437	$74.50	$32,556	2,068
2021-05-01	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Exercise / conversion M · derivative	Restricted Stock Unit	622	$0.00	$0	1,245
2021-05-01	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Other disposed transaction F	Common Stock	210	$74.50	$15,645	1,631
2021-05-01	LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	Exercise / conversion M	Common Stock	622	$74.50	$46,339	1,841
2021-03-31	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	389	$77.09	$30,000	100,545
2021-03-15	Mayo Stephen	Dir	Equity grant / award A · derivative	Phantom Stock	120	$76.23	$9,140	120
2021-02-26	Li Dean Y	Executive VP & President, MRL	Equity grant / award A	Common Stock	3,485	$72.62	$253,081	10,655
2021-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,167	$0.00	$0	2,335
2021-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Other disposed transaction F	Common Stock	467	$75.04	$35,044	3,193
2021-02-10	Williams David Michael	EVP,Chief Info&Digital Officer	Exercise / conversion M	Common Stock	1,167	$75.04	$87,572	3,660
2020-12-31	Coe Mary Ellen	Dir	Equity grant / award A · derivative	Phantom Stock	397	$81.80	$32,500	7,857
2020-11-09	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	144,866	$81.74	$11,840,941	411,546
2020-11-09	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	135,134	$81.08	$10,956,070	556,412
2020-10-30	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	2,287	$0.00	$0	2,288
2020-10-30	Clyburn Frank	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock	1,137	$75.89	$86,287	82,519
2020-10-30	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock	2,287	$75.89	$173,560	83,656
2020-10-05	Davis Robert M	EVP, Global Svcs & CFO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	251,273	$0.00	$0	0
2020-10-05	Davis Robert M	EVP, Global Svcs & CFO	Open-market sell S	Common Stock	251,273	$81.03	$20,360,325	171,056
2020-10-05	Davis Robert M	EVP, Global Svcs & CFO	Exercise / conversion M	Common Stock	251,273	$0.00	$0	422,329
2020-09-30	Seidman Christine E	Dir	Equity grant / award A · derivative	Phantom Stock	196	$82.95	$16,250	3,054
2020-08-13	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	10,380	$83.01	$861,676	67,373
2020-08-05	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	18,876	$0.00	$0	0
2020-08-05	Clyburn Frank	EVP, Chief Commercial Officer	Open-market sell S	Common Stock	18,876	$81.55	$1,539,274	80,763
2020-08-05	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock	18,876	$0.00	$0	99,639
2020-07-17	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Exercise / conversion M · derivative	Stock Option (Right to Buy)	18,111	$0.00	$0	0
2020-07-17	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Open-market sell S	Common Stock	18,174	$80.01	$1,454,096	26,577
2020-07-17	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Open-market sell S	Common Stock	18,111	$80.00	$1,448,880	44,751
2020-07-17	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Exercise / conversion M	Common Stock	18,111	$0.00	$0	62,862
2020-06-30	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	388	$77.33	$30,000	97,157
2020-05-29	Thulin Inge G	Dir	Equity grant / award A · derivative	Phantom Stock	2,478	$80.72	$200,000	10,326
2020-05-07	WEEKS WENDELL P	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	5,000	$0.00	$0	0
2020-05-07	WEEKS WENDELL P	Dir	Open-market sell S	Common Stock	5,000	$76.02	$380,104	100
2020-05-07	WEEKS WENDELL P	Dir	Exercise / conversion M	Common Stock	5,000	$0.00	$0	5,100
2020-05-05	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,752	$0.00	$0	0
2020-05-05	Clyburn Frank	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock	1,848	$76.86	$142,037	80,763
2020-05-05	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock	3,752	$76.86	$288,379	82,611
2020-05-04	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,904	$0.00	$0	1,906
2020-05-04	Clyburn Frank	EVP, Chief Commercial Officer	Other disposed transaction F	Common Stock	938	$77.67	$72,854	78,859
2020-05-04	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock	1,904	$77.67	$147,884	79,797
2020-05-01	Zachary Jennifer	EVP, General Counsel	Equity grant / award A · derivative	Stock Option (Right to Buy)	75,514	$0.00	$0	75,514
2020-03-31	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	390	$76.94	$30,000	93,567
2020-03-16	Warden Kathy J	Dir	Equity grant / award A · derivative	Phantom Stock	114	$69.92	$7,957	114
2020-02-28	PERLMUTTER ROGER M	Exe V-P & Pres, MRL	Equity grant / award A	Common Stock	35,049	$76.56	$2,683,351	214,428
2020-01-13	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Exercise / conversion M · derivative	Stock Option (Right to Buy)	33,012	$0.00	$0	0
2020-01-13	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Exercise / conversion M · derivative	Stock Option (Right to Buy)	49,536	$0.00	$0	0
2020-01-13	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Open-market sell S	Common Stock	102,073	$89.34	$9,118,865	37,038
2020-01-13	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Exercise / conversion M	Common Stock	33,012	$0.00	$0	139,111
2020-01-13	Gerberding Julie L.	EVP Strat Comm, GI Pub Policy	Exercise / conversion M	Common Stock	49,536	$0.00	$0	106,099
2019-12-31	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	316	$90.95	$28,750	92,542
2019-10-30	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M · derivative	Restricted Stock Unit	4,574	$85.10	$389,247	9,149
2019-10-30	MIZELL STEVEN	EVP, Chief HR Officer	Other disposed transaction F	Common Stock	1,567	$85.10	$133,352	3,007
2019-10-30	MIZELL STEVEN	EVP, Chief HR Officer	Exercise / conversion M	Common Stock	4,574	$0.00	$0	4,574
2019-09-30	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	342	$84.18	$28,750	91,631
2019-08-09	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M · derivative	Stock Option (Right to Buy)	6,427	$0.00	$0	0
2019-08-09	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Open-market sell S	Common Stock	6,427	$85.09	$546,850	71,524
2019-08-09	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M	Common Stock	6,427	$0.00	$0	77,951
2019-08-08	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M · derivative	Stock Option (Right to Buy)	31,699	$0.00	$0	6,427
2019-08-08	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Open-market sell S	Common Stock	31,699	$85.01	$2,694,789	71,524
2019-08-08	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M	Common Stock	31,699	$0.00	$0	103,223
2019-06-28	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	343	$83.85	$28,750	90,699
2019-06-25	Davis Robert M	EVP, Global Svcs & CFO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	216,718	$0.00	$0	0
2019-06-25	Davis Robert M	EVP, Global Svcs & CFO	Open-market sell S	Common Stock	26,550	$86.00	$2,283,345	137,660
2019-06-25	Davis Robert M	EVP, Global Svcs & CFO	Open-market sell S	Common Stock	190,168	$85.35	$16,230,687	164,210
2019-06-25	Davis Robert M	EVP, Global Svcs & CFO	Exercise / conversion M	Common Stock	216,718	$0.00	$0	354,378
2019-05-31	WEEKS WENDELL P	Dir	Equity grant / award A · derivative	Phantom Stock	2,336	$79.21	$185,000	89,295
2019-05-10	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M · derivative	Restricted Stock Unit	3,292	$78.33	$257,862	0
2019-05-10	Karachun Rita A	Sr. VP Fince-Global Controller	Other disposed transaction F	Common Stock	1,622	$78.33	$127,051	20,790
2019-05-10	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M	Common Stock	3,292	$0.00	$0	22,412
2019-05-07	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	25,000	$0.00	$0	18,876
2019-05-07	Clyburn Frank	EVP, Chief Commercial Officer	Open-market sell S	Common Stock	25,000	$77.73	$1,943,182	67,604
2019-05-07	Clyburn Frank	EVP, Chief Commercial Officer	Exercise / conversion M	Common Stock	25,000	$39.29	$982,250	92,604
2019-05-06	FRAZIER KENNETH C	Chairman, President & CEO	Equity grant / award G	Common Stock	14,623	$0.00	$0	783,092
2019-05-03	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M · derivative	Stock Option (right to buy)	35,000	$0.00	$0	38,126
2019-05-03	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Equity grant / award A · derivative	Stock Option (right to buy)	56,454	$0.00	$0	56,454
2019-05-03	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Open-market sell S	Common Stock	35,000	$80.00	$2,800,000	71,064
2019-05-03	DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Exercise / conversion M	Common Stock	35,000	$39.29	$1,375,150	106,064
2019-05-03	Fleming Michael	SVP Chief Ethics & Com Officer	Equity grant / award A · derivative	Restricted Stock Unit	4,625	$0.00	$0	4,625
2019-04-08	Merck & Co., Inc.	10%	Exercise / conversion C · derivative	Series E Convertible Preferred Stock	17,666,666	$0.00	$0	0
2019-04-08	Merck & Co., Inc.	10%	Open-market buy P	Common Stock	4,121,683	$16.00	$65,946,928	12,955,016
2019-04-08	Merck & Co., Inc.	10%	Exercise / conversion C	Common Stock	8,833,333	—	—	8,833,333
2019-03-29	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	346	$83.17	$28,750	87,430
2019-03-25	Davis Robert M	EVP, Global Svcs & CFO	Exercise / conversion M · derivative	Stock Option (right to buy)	192,572	$0.00	$0	0
2019-03-25	Davis Robert M	EVP, Global Svcs & CFO	Open-market sell S	Common Stock	192,572	$82.38	$15,863,118	137,660
2019-03-25	Davis Robert M	EVP, Global Svcs & CFO	Exercise / conversion M	Common Stock	192,572	$58.22	$11,211,542	330,232
2019-03-20	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	192,736	$0.00	$0	0
2019-03-20	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	192,736	$82.05	$15,813,372	797,715
2019-03-20	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	192,736	$39.29	$7,572,597	990,451
2019-03-18	Coe Mary Ellen	Dir	Equity grant / award A · derivative	Phantom Stock	79	$81.35	$6,398	79
2019-03-13	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	18,725	$0.00	$0	192,736
2019-03-13	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	18,725	$82.00	$1,535,454	797,715
2019-03-13	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	18,725	$39.29	$735,705	816,440
2019-03-05	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	6,961	$0.00	$0	211,461
2019-03-05	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	6,961	$82.00	$570,809	797,715
2019-03-05	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	6,961	$39.29	$273,498	804,676
2019-03-04	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	13,144	$0.00	$0	218,422
2019-03-04	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	13,144	$82.01	$1,077,875	797,715
2019-03-04	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	13,144	$39.29	$516,428	810,859
2019-02-25	PERLMUTTER ROGER M	Exe V-P & Pres, MRL	Equity grant / award A	Common Stock	32,937	$80.38	$2,647,476	175,336
2019-02-22	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	53,961	$0.00	$0	231,566
2019-02-22	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	53,961	$80.02	$4,318,089	691,950
2019-02-22	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	53,961	$39.29	$2,120,128	745,911
2019-02-21	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	41,992	$0.00	$0	285,527
2019-02-21	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	41,992	$80.00	$3,359,452	691,950
2019-02-21	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	41,992	$39.29	$1,649,866	733,942
2019-02-19	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	42,700	$0.00	$0	327,519
2019-02-19	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	42,700	$80.02	$3,416,944	691,950
2019-02-19	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	42,700	$39.29	$1,677,683	734,650
2019-02-15	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	92,913	$0.00	$0	370,219
2019-02-15	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	92,913	$80.03	$7,436,162	691,950
2019-02-15	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	92,913	$39.29	$3,650,552	784,863
2019-02-14	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M · derivative	Stock Option (right to buy)	27,510	$0.00	$0	0
2019-02-14	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M · derivative	Stock Option (right to buy)	37,152	$0.00	$0	0
2019-02-14	Karachun Rita A	Sr. VP Fince-Global Controller	Open-market sell S	Common Stock	64,662	$78.96	$5,105,951	16,175
2019-02-14	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M	Common Stock	27,510	$58.22	$1,601,632	80,837
2019-02-14	Karachun Rita A	Sr. VP Fince-Global Controller	Exercise / conversion M	Common Stock	37,152	$59.86	$2,223,919	53,327
2019-02-13	WEEKS WENDELL P	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	0
2019-02-13	WEEKS WENDELL P	Dir	Open-market sell S	Common Stock	5,000	$78.71	$393,548	100
2019-02-13	WEEKS WENDELL P	Dir	Exercise / conversion M	Common Stock	5,000	$24.30	$121,500	5,100
2019-02-12	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (right to buy)	29,851	$0.00	$0	0
2019-02-12	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (right to buy)	43,876	$0.00	$0	0
2019-02-12	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	73,727	$78.62	$5,796,306	51,467
2019-02-12	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	29,851	$36.56	$1,091,353	125,194
2019-02-12	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	43,876	$39.29	$1,723,888	95,343
2019-02-08	BRUN LESLIE A	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	0
2019-02-08	BRUN LESLIE A	Dir	Open-market sell S	Common Stock	3,052	$77.22	$235,681	1,948
2019-02-08	BRUN LESLIE A	Dir	Exercise / conversion M	Common Stock	5,000	$24.30	$121,500	5,000
2019-02-05	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	231,566	$0.00	$0	463,132
2019-02-05	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	231,566	$78.08	$18,079,654	691,950
2019-02-05	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	231,566	$39.29	$9,098,228	923,516
2019-02-04	GLOCER THOMAS H	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	0
2019-02-04	GLOCER THOMAS H	Dir	Open-market sell S	Common Stock	10,000	$75.96	$759,590	5,100
2019-02-04	GLOCER THOMAS H	Dir	Exercise / conversion M	Common Stock	5,000	$24.30	$121,500	15,100
2018-12-31	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	376	$76.41	$28,750	86,461
2018-11-08	PERLMUTTER ROGER M	Exe V-P & Pres, MRL	Exercise / conversion M · derivative	Stock Option (right to buy)	225,443	$0.00	$0	0
2018-11-08	PERLMUTTER ROGER M	Exe V-P & Pres, MRL	Open-market sell S	Common Stock	225,443	$75.27	$16,967,967	141,555
2018-11-08	PERLMUTTER ROGER M	Exe V-P & Pres, MRL	Exercise / conversion M	Common Stock	225,443	$44.98	$10,140,426	366,998
2018-11-07	Gerberding Julie L.	EVP Strat Comm, Gl Pub Policy	Exercise / conversion M · derivative	Stock Option (right to buy)	36,218	$0.00	$0	18,111
2018-11-07	Gerberding Julie L.	EVP Strat Comm, Gl Pub Policy	Open-market sell S	Common Stock	36,218	$75.14	$2,721,348	46,263
2018-11-07	Gerberding Julie L.	EVP Strat Comm, Gl Pub Policy	Exercise / conversion M	Common Stock	36,218	$54.68	$1,980,400	82,481
2018-11-01	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M · derivative	Stock Option (right to buy)	277,879	$0.00	$0	0
2018-11-01	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	145,135	$73.66	$10,691,181	0
2018-11-01	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	132,744	$73.98	$9,819,764	145,135
2018-11-01	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M	Common Stock	277,879	$39.29	$10,917,866	277,879
2018-10-31	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	18,110	$0.00	$0	9,055
2018-10-31	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	5,706	$0.00	$0	11,412
2018-10-31	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	23,220	$0.00	$0	0
2018-10-31	Watson Ashley	SVP Chief Ethics & Com Officer	Open-market sell S	Common Stock	47,036	$74.33	$3,496,158	9,770
2018-10-31	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M	Common Stock	5,706	$63.97	$365,013	56,806
2018-10-31	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M	Common Stock	18,110	$54.68	$990,255	51,100
2018-10-31	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M	Common Stock	23,220	$59.86	$1,389,949	32,990
2018-10-30	DeLuca Richard R.	EVP&Pres, Merck Animal Health	Exercise / conversion M · derivative	Stock Option (right to buy)	25,467	$0.00	$0	0
2018-10-30	DeLuca Richard R.	EVP&Pres, Merck Animal Health	Open-market sell S	Common Stock	25,467	$72.00	$1,833,739	56,668
2018-10-30	DeLuca Richard R.	EVP&Pres, Merck Animal Health	Exercise / conversion M	Common Stock	25,467	$34.19	$870,717	82,135
2018-10-02	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	279,850	$0.00	$0	0
2018-10-02	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	279,850	$72.07	$20,168,258	691,950
2018-10-02	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	279,850	$36.56	$10,231,316	971,800
2018-10-01	Merck & Co., Inc.	10%	Exercise / conversion C · derivative	Series E Redeemable Convertible Preferred Stock	74,794,315	$0.00	$0	0
2018-10-01	Merck & Co., Inc.	10%	Open-market buy P	Common Stock	666,666	$15.00	$9,999,990	2,723,509
2018-10-01	Merck & Co., Inc.	10%	Exercise / conversion C	Common Stock	2,056,843	—	—	2,056,843
2018-09-28	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	405	$70.94	$28,750	85,510
2018-09-18	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	279,851	$0.00	$0	279,850
2018-09-18	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	279,851	$70.08	$19,611,818	691,950
2018-09-18	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	279,851	$36.56	$10,231,353	971,801
2018-09-17	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M · derivative	Stock Option (right to buy)	100,000	$0.00	$0	0
2018-09-17	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	7,360	$70.18	$516,511	55,406
2018-09-17	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	100,000	$70.18	$7,017,780	0
2018-09-17	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M	Common Stock	100,000	$36.56	$3,656,000	100,000
2018-08-03	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (right to buy)	19,208	$0.00	$0	0
2018-08-03	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M · derivative	Stock Option (right to buy)	10,000	$0.00	$0	0
2018-08-03	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Open-market sell S	Common Stock	29,208	$65.20	$1,904,362	51,467
2018-08-03	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	10,000	$37.49	$374,900	80,675
2018-08-03	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Exercise / conversion M	Common Stock	19,208	$33.49	$643,276	70,675
2018-08-02	Karachun Rita A	Sr. VP Fince-Global Controller	Open-market sell S	Common Stock	5,000	$65.01	$325,040	16,175
2018-07-31	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M · derivative	Stock Option (right to buy)	228,091	$0.00	$0	0
2018-07-31	FRAZIER KENNETH C	Chairman, President & CEO	Equity grant / award G	Common Stock	18,747	$0.00	$0	691,950
2018-07-31	FRAZIER KENNETH C	Chairman, President & CEO	Open-market sell S	Common Stock	228,091	$65.00	$14,826,691	710,697
2018-07-31	FRAZIER KENNETH C	Chairman, President & CEO	Exercise / conversion M	Common Stock	228,091	$33.49	$7,638,768	938,788
2018-06-29	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	474	$60.70	$28,750	84,455
2018-06-18	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M · derivative	Stock Option (right to buy)	100,000	$0.00	$0	100,000
2018-06-18	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	34,094	$61.00	$2,079,785	62,766
2018-06-18	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	100,000	$61.00	$6,100,160	0
2018-06-18	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M	Common Stock	100,000	$36.56	$3,656,000	100,000
2018-05-25	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	3,131	$59.09	$185,000	83,981
2018-05-15	Gerberding Julie L.	EVP Strat Comm, Gl Pub Policy	Open-market sell S	Common Stock	9,972	$59.66	$594,963	45,717
2018-05-04	Zachary Jennifer	EVP, General Counsel	Equity grant / award A · derivative	Stock Option (right to buy)	73,191	$0.00	$0	73,191
2018-05-04	Zachary Jennifer	EVP, General Counsel	Equity grant / award A · derivative	Restricted Stock Unit	17,316	$0.00	$0	17,316
2018-05-01	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M · derivative	Restricted Stock Unit	10,441	$58.87	$614,662	0
2018-05-01	Watson Ashley	SVP Chief Ethics & Com Officer	Other disposed transaction F	Common Stock	3,151	$58.87	$185,499	9,632
2018-05-01	Watson Ashley	SVP Chief Ethics & Com Officer	Exercise / conversion M	Common Stock	10,441	$0.00	$0	12,783
2018-04-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Open-market sell S	Common Stock	24,000	$58.00	$1,392,000	80,433
2018-04-02	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	540	$53.27	$28,750	80,134
2018-03-01	THULIN INGE G	Dir	Equity grant / award A · derivative	Phantom Stock	264	$53.70	$14,167	264
2018-02-27	Karachun Rita A	Sr. VP Fince-Global Controller	Equity grant / award A	Common Stock	3,090	$54.72	$169,085	19,198
2018-02-09	WEEKS WENDELL P	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	0
2018-02-09	WEEKS WENDELL P	Dir	Open-market sell S	Common Stock	5,000	$53.57	$267,833	100
2018-02-09	WEEKS WENDELL P	Dir	Exercise / conversion M	Common Stock	5,000	$38.04	$190,200	5,100
2018-01-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Exercise / conversion M · derivative	Stock Option (right to buy)	52,000	$0.00	$0	0
2018-01-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Open-market sell S	Common Stock	52,000	$61.63	$3,204,760	93,484
2018-01-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Open-market sell S	Common Stock	8,000	$61.63	$493,040	145,484
2018-01-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Exercise / conversion M	Common Stock	52,000	$44.30	$2,303,600	153,484
2018-01-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Open-market sell S	Common Stock	52,000	$61.63	$3,204,760	90,484
2018-01-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Open-market sell S	Common Stock	8,000	$61.63	$493,040	142,484
2018-01-16	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Exercise / conversion M	Common Stock	52,000	$44.30	$2,303,600	150,484
2018-01-16	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M · derivative	Stock Option (right to buy)	50,994	$0.00	$0	200,000
2018-01-16	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	50,608	$61.63	$3,118,971	62,766
2018-01-16	Schechter Adam H	EVP & Pres-Global Human Health	Open-market sell S	Common Stock	50,994	$61.63	$3,142,760	0
2018-01-16	Schechter Adam H	EVP & Pres-Global Human Health	Exercise / conversion M	Common Stock	50,994	$36.56	$1,864,341	50,994
2018-01-12	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Open-market sell S	Common Stock	5,000	$58.00	$290,000	101,484
2018-01-12	GRADDICK WEIR MIRIAN M	Exe V-P, HR	Open-market sell S	Common Stock	8,000	$58.00	$464,000	98,484
2017-12-29	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	489	$56.27	$27,500	78,930
2017-12-15	Schechter Adam H	EVP & Pres-Global Human Health	Equity grant / award G	Common Stock	750	$0.00	$0	113,374
2017-11-09	Chattopadhyay Sanat	Exe V-P & Pres. MMD	Other acquired transaction I · derivative	Phantom Stock	13,100	$56.21	$736,324	13,123
2017-11-08	GLOCER THOMAS H	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	0
2017-11-08	GLOCER THOMAS H	Dir	Open-market sell S	Common Stock	5,000	$56.20	$280,982	5,100
2017-11-08	GLOCER THOMAS H	Dir	Exercise / conversion M	Common Stock	5,000	$38.04	$190,200	10,100
2017-09-29	WENDELL PETER C	Dir	Equity grant / award A · derivative	Phantom Stock	429	$64.03	$27,500	77,877
2016-08-04	AMBROSE ADELE D	Sr.V-P & Chief Comuns Officer	Open-market sell S	Common Stock	7,000	$57.80	$404,600	17,876

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count